.png)
COVID-19 Evidence Reviews
as of 5/14/21
= living review
= meets mimimum quality standards | A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
 latest update date
 |
select |
|
|---|---|---|
|
5/13/21
|
Oyibo K, Sahu KS, Oetomo A, et al. | JMIR Res Protoc
|
|
|
5/10/21
|
Pensel MC, Fink J | PROSPERO
|
|
|
5/10/21
|
Shirvaliloo M, Sheervalilou R, Baghi HB | PROSPERO
|
|
|
5/10/21
|
Dhanani J, Roberts J | PROSPERO
|
|
|
5/10/21
|
Mattiello R, Scarpatto C, Borba E, et al | PROSPERO
|
|
|
5/10/21
|
Ayerbe L, Forgnone I, Ayis S | PROSPERO
|
|
|
5/10/21
|
Chrystoja B, Shield K, Rehm J, et al | PROSPERO
|
|
|
5/10/21
|
Jeddi SA, Rizi ZT, Bahadori T, et al | PROSPERO
|
|
|
5/10/21
|
Churchill R, Riadi I, Kervin L, et al. | Syst Rev
|
|
|
5/10/21
|
Dahms K, Ansems K, Benstöm C, et al | PROSPERO
|
|
|
5/10/21
|
Ghashghaee A, Kan FP, Rafiei S, et al | PROSPERO
|
|
|
5/10/21
|
Acharya A, Iqbal F, Sounderajah V, et al | PROSPERO
|
|
|
5/10/21
|
Wafa IA, Pratama NR, Sofia NF, et al | PROSPERO
|
|
|
5/10/21
|
Feltham L, Galatis D, Banh HL, et al | PROSPERO
|
|
|
5/10/21
|
Hasan F, Budi HS | PROSPERO
|
|
|
5/10/21
|
Khobragafe A, Agrawal N | PROSPERO
|
|
|
5/10/21
|
Zhu J, Racine N, Eirich R, et al | PROSPERO
|
|
|
5/10/21
|
Peter YTW, Juruena M, Young A | PROSPERO
|
|
|
5/10/21
|
Liu N, Zhang T, Ma L, et al | PROSPERO
|
|
|
5/10/21
|
Velickovic V, Sun S, Abdelaziz AB, et al | PROSPERO
|
|
|
5/10/21
|
The determinants and correlates of physical activity amidst the COVID-19 pandemic in healthy adults.
Smith S, Carter B, Prapavessis H, et al | PROSPERO
|
|
|
5/10/21
|
Zhang L, Wang J, Feng G, et al | PROSPERO
|
|
|
5/10/21
|
Schneider J, Craddock N, Forshaw M, et al | PROSPERO
|
|
|
5/10/21
|
Alboksmaty A, Beany T, Neves AL, et al | PROSPERO
|
|
|
5/7/21
|
Schwendinger F, Pocecco E, Infanger D, et al | PROSPERO
|
|
|
5/7/21
|
Araujo C, Carvalho S, Vêncio E | PROSPERO
|
|
|
5/7/21
|
Prakash H, Kalaiselvi V, Chakravarthy P | PROSPERO
|
|
|
5/7/21
|
Galatis D, Banh HL, Cave A, et al | PROSPERO
|
|
|
5/7/21
|
Ahenda P, Appiah B, Mutayoba B | PROSPERO
|
|
|
5/7/21
|
Temeng E, Anstey S, Bundy C, et al | PROSPERO
|
|
|
5/7/21
|
Sanfilippo F, Astuto M | PROSPERO
|
|
|
5/7/21
|
Qian Y, Xu H, Diao J, et al. | Medicine
|
|
|
5/7/21
|
Bianco C, Guidet B, Flaatten H, et al | PROSPERO
|
|
|
5/7/21
|
Ribeiro T, Herdeiro MT, Roque F, et al | PROSPERO
|
|
|
5/7/21
|
Ribeiro T, Roque F, Herdeiro MT, et al | PROSPERO
|
|
|
5/7/21
|
Morales-Cane I, del Rocío VL, López-Soto PJ | PROSPERO
|
|
|
5/7/21
|
Suelves JM, Gomez-Zuñiga B, Armayones M | PROSPERO
|
|
|
5/7/21
|
Weerasekara I, Pathirana M, Kalhari R, et al | PROSPERO
|
|
|
5/6/21
|
Mangoni A, Zinelli A | PROSPERO
|
|
|
5/6/21
|
Song W, Wangwang K | PROSPERO
|
|
|
5/6/21
|
Gil-Rodrigo A, Llorens P, Martínez-Buendía, et al | PROSPERO
|
|
|
5/6/21
|
Dilokthornsakul P, Thakkinstian A, Hutubessy R, et al | PROSPERO
|
|
|
5/6/21
|
Cicolini G, Simonetti V, Comparcini D, et al | PROSPERO
|
|
|
5/6/21
|
Hamza SB, Abdalla YA, Mustafa AAM, et al | PROSPERO
|
|
|
5/6/21
|
Drea A, Nangare C | PROSPERO
|
|
|
5/6/21
|
Torres AA, Jonathan C | PROSPERO
|
|
|
5/6/21
|
de Oliveira Silva DF, Cobucci RN, Lima SCVC, et al. | medRxiv
Aim: To identify the prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic. RECENTLY UPDATED
|
|
|
5/6/21
|
Zhao H, Huang S, Mei K, et al. | medRxiv
Aim: To review the evidence on the effects of non-steroidal anti-inflammatory drugs in patients with COVID-19.
|
|
|
5/6/21
|
Cruz-Ausejo L, Villarreal-Zegarra D, Reátegui-Rivera CM, et al | PROSPERO
|
|
|
5/6/21
|
Dzinamarira T, Mhango M, Dzobo M, et al. | PLoS One
|
|
|
5/6/21
|
Zhou X, Zhong L, Wang W, et al | PROSPERO
|
|
|
5/5/21
|
Meixueiro VHO, Campos EP | PROSPERO
|
|
|
5/5/21
|
Patra P, Das RR, Chaudhary H, et al | PROSPERO
|
|
|
5/5/21
|
Saragih ID, Saragih IS, Tonapa SI | PROSPERO
|
|
|
5/5/21
|
Throne T, Estabrooks C | PROSPERO
|
|
|
5/5/21
|
Prabani KIP, Damayanthi HDWT | PROSPERO
|
|
|
5/5/21
|
Little T, Reinhard D, White S | PROSPERO
|
|
|
5/5/21
|
Niemi M, Flodi P, Osika W, et al | PROSPERO
|
|
|
5/5/21
|
Silva F, Stein A, Lima J, et al | PROSPERO
|
|
|
5/5/21
|
Badenoch J, Rengasamy ER, Watson CJ, et al. | medRxiv
Aim: To determine the prevalence of neuropsychiatric symptoms in survivors of COVID-19. RECENTLY UPDATED
|
|
|
5/5/21
|
Leal Cortez AC, Dantas EHM | PROSPERO
|
|
|
5/5/21
|
Di Liberto A, Biagianti B, Aiello N, et al | PROSPERO
|
|
|
5/5/21
|
SARS-CoV2 pandemic effects on healthcare workers' mental health: Systematic review and meta-analysis
Aymerich C, Pedruzo B, Andres L, et al | PROSPERO
|
|
|
5/5/21
|
Austin M, Gersberg R | PROSPERO
|
|
|
5/5/21
|
Csupor D, Toth B, Matuz M, et al | PROSPERO
|
|
|
5/5/21
|
Zhang CN, Jiahui L | PROSPERO
|
|
|
5/5/21
|
Zhang C, Jiahui L | PROSPERO
|
|
|
5/5/21
|
Uaprasert N, Panrong K, Chiasakul T | PROSPERO
|
|
|
5/5/21
|
Dowsett L, Egunsola O, Clement F, et al | PROSPERO
|
|
|
5/4/21
|
Aasim S, Ahmed S | PROSPERO
|
|
|
5/4/21
|
Benzouak T, Rao S, Gunpat S, et al | PROSPERO
|
|
|
5/4/21
|
Vedovati MC, Graziani M, Becattini C | PROSPERO
|
|
|
5/4/21
|
Leonart L, Pontarolo R, Ribeiro M, et al | PROSPERO
|
|
|
5/4/21
|
Saragih ID, Saragih IS | PROSPERO
|
|
|
5/4/21
|
Melo dos Santos AC, Farias KF, de Seuza Figueiredo | PROSPERO
|
|
|
5/4/21
|
Sidarta C, Kurniawan A | PROSPERO
|
|
|
5/4/21
|
Fei Z, Chen Z, Du X, et al | PROSPERO
|
|
|
5/4/21
|
Molteni A, Manfredi M, Ghulam A, et al | PROSPERO
|
|
|
5/4/21
|
Özkan I, Taylan S | PROSPERO
|
|
|
5/4/21
|
Meyer D, Ogungbe B, Farley J | PROSPERO
|
|
|
5/4/21
|
Waqar U, Ahmed S, Hussain A, et al | PROSPERO
|
|
|
5/4/21
|
Mueller A, Skoetz N, Piechotta V, et al | PROSPERO
|
|
|
5/3/21
|
Khodayari-Zarnaq R, Dehghani A, Azami-Aghdash S, et al | PROSPERO
|
|
|
5/3/21
|
Ciapponi A, Bardach A, Comande D, et al. | medRxiv
Aim: To summarize the best evidence regarding the effect of COVID-19 on maternal and child health.
|
|
|
5/3/21
|
Kotfis K, Skonieczna-?ydecka K, ?oniewski I, et al | PROSPERO
|
|
|
5/3/21
|
Lu C, Dong F, Liu H, et al | PROSPERO
|
|
|
5/3/21
|
Coclite D, Napoletano A, Iannone P, et a | PROSPERO
|
|
|
5/3/21
|
Hugh-Jones S, Prabhu S, Podiya JK, et al | PROSPERO
|
|
|
5/3/21
|
Hugh-Jones S, Prabhu S, Podiya JK, et al | PROSPERO
|
|
|
4/30/21
|
Parthasarathi A, Mahesh PA, Padukudru S, et al | PROSPERO
|
|
|
4/30/21
|
Wang J, Liu K, Zhang L | PROSPERO
|
|
|
4/30/21
|
Cashman A, Murphy M | PROSPERO
|
|
|
4/30/21
|
Ting Wong TH, Liang W, Luo S, et al | PROSPERO
|
|
|
4/30/21
|
Nursanti I, Yunitri N, Kurwiyah N, et al | PROSPERO
|
|
|
4/30/21
|
Sousa G, Galvão-Coelho N, Tavares V, et al | PROSPERO
|
|
|
4/30/21
|
Carnauba ATL, da Costa KVT, Madeiro LB, et al | PROSPERO
|
|
|
4/30/21
|
Barlinn K, Siepmann T, Sedghi A, et al | PROSPERO
|
|
|
4/30/21
|
Faruque M, Laine M, Bikker F | PROSPERO
|
|
|
4/30/21
|
Cassimiro Inacio ML, Mendes LL, Borges LD, et al | PROSPERO
|
|
|
4/30/21
|
Damara F, Faried A | PROSPERO
|
|
|
4/29/21
|
Deb P, Bhuiyan AH, Talukder S, et al | PROSPERO
|
|
|
4/29/21
|
Nunes ML, Richter S, Wearick-Silva LE | PROSPERO
|
|
|
4/29/21
|
Alves DE, Rogeberg O, Mamelund SE | PROSPERO
|
|
|
4/29/21
|
Rahman MM, Chowdhury U, Hasan MN, et al | PROSPERO
|
|
|
4/29/21
|
Balanzá-Martínez V, Méndez R, Grevet EH, et al | PROSPERO
|
|
|
4/29/21
|
Hessami K, Shamshirsaz A | PROSPERO
|
|
|
4/29/21
|
Ayosanmi O, Akingbule O, Akingbule A, et al | PROSPERO
|
|
|
4/29/21
|
Jiao B, Chen M | PROSPERO
|
|
|
4/29/21
|
D'Andrea N, Saccomanno S, Quinzi V, et al | PROSPERO
|
|
|
4/29/21
|
Grealish A, Tzouvara V, DeRijik L, et al | PROSPERO
|
|
|
4/28/21
|
Yang S, Tsai SHL | PROSPERO
|
|
|
4/28/21
|
Xu J, Noorbhai L, Patel A, et al | PROSPERO
|
|
|
4/28/21
|
Parthasarathi A, Puvvada R, Padukudru S, et al | PROSPERO
|
|
|
4/28/21
|
Walker E, Hood A, Kirkham F | PROSPERO
|
|
|
4/27/21
|
Rao S, Benzouak T, Gunpat S, et al. | medRxiv
Aim: To evaluate the prevalence of fatigue in post-recovery from SARS-CoV-2 infection. UPDATED
|
|
|
4/27/21
|
Gates M, Pillay J, Wingert A, et al. | medRxiv
Aim: To inform vaccine prioritization guidance by the National Advisory Committee on Immunization (NACI). UPDATED
|
|
|
4/27/21
|
Podmore B, Qizilbash N, Lacetera A, et al. | medRxiv
Aim: To summarise and compare evidence from randomised controlled trials and observational studies of the effect of tocilizumab on in-hospital mortality in patients with COVID-19. UPDATED
|
|
|
4/26/21
|
Burton G, Carver H, Parkes T, et al | PROSPERO
|
|
|
4/26/21
|
Wang T, Wang M, Yang D | PROSPERO
|
|
|
4/26/21
|
Alqahtani S, Abdul Razack HI, Mathew S, et al | PROSPERO
|
|
|
4/26/21
|
Dolz del Castellar B, Lara E, Castelletti C, et al | PROSPERO
|
|
|
4/26/21
|
Li L, Moosbrugger M | PROSPERO
|
|
|
4/26/21
|
Luo X, Lv M, Yang B, et al | PROSPERO
|
|
|
4/26/21
|
Bossard M, Kofler T, Kurmann R, et al | PROSPERO
|
|
|
4/26/21
|
Eslami G, Markowitz J, Moradimajd P, Samaee H, et al | PROSPERO
|
|
|
4/26/21
|
Meng X, Liu Y, Huang X, et al | PROSPERO
|
|
|
4/26/21
|
Zhang S, Chen Z | PROSPERO
|
|
|
4/26/21
|
Misra S, Kolappa K, Prasad M, et al. | MedRxiv
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality. UPDATED
|
|
|
4/26/21
|
Iness Audra, Cockburn C, Cyrus J, et al | PROSPERO
|
|
|
4/26/21
|
Marchand G, Ware K, Taher A, et al | PROSPERO
|
|
|
4/26/21
|
El Hayek G, Berry I, Wong B, et al | PROSPERO
|
|
|
4/26/21
|
Sliwka A, Kaszuba M, Pilinski R, et al | PROSPERO
|
|
|
4/26/21
|
Purwanti OS, Sudaryanto A | PROSPERO
|
|
|
4/26/21
|
Bai Y, Yan Z, Murray EJ | medRxiv
Aim: To review the literature on COVID-19 and ABO blood type to assess the quality of the evidence for or against a relationship between ABO blood type and COVID-19 risk and severity.
|
|
|
4/26/21
|
Shah R, Dhital R, Carmina S | PROSPERO
|
|
|
4/26/21
|
Maharani A, Sujarwoto S, Tampubolon G, et al | PROSPERO
|
|
|
4/26/21
|
Vinade Chagas ME, Junqueira D, Wienekiewicz S, et al | PROSPERO
|
|
|
4/23/21
|
Kamarullah W, Sabrina AP, Rocky MA, et al | PROSPERO
|
|
|
4/23/21
|
Sakthivel M, Rubeshkumar P, Ganeshkumar P, et al | PROSPERO
|
|
|
4/23/21
|
Katzenschlager S, Denkinger C, Brümmer L, et al | PROSPERO
|
|
|
4/23/21
|
Dayan V, Florio L, Vignolo G, et al | PROSPERO
|
|
|
4/23/21
|
Reis S, Morais C, Valente E, et al | PROSPERO
|
|
|
4/23/21
|
Price R, Kelly C, Macleod U, et al | PROSPERO
|
|
|
4/23/21
|
Jennings G, Romero-Ortuño R, Monaghan A, et al | PROSPERO
|
|
|
4/23/21
|
Corrêa F, Nascimento A, Ribeiro L | PROSPERO
|
|
|
4/23/21
|
Lee KW, Ooi PB | PROSPERO
|
|
|
4/23/21
|
| PROSPERO
|
|
|
4/22/21
|
Dawson A, Pemble C, Brown T, et al | PROSPERO
|
|
|
4/22/21
|
Peng A, Sun B, He Y | PROSPERO
|
|
|
4/22/21
|
Peng D, Li J | PROSPERO
|
|
|
4/22/21
|
Palaiodimou L, Stefanou MI, Katsanos A, et al. | PROSPERO
|
|
|
4/22/21
|
Chakafana G, Aremu O, Mutithu D, et al | PROSPERO
|
|
|
4/22/21
|
Silveira I, Loureiro S | PROSPERO
|
|
|
4/22/21
|
Olorunda O, Henderson K, Okoro K, et al | PROSPERO
|
|
|
4/22/21
|
Selvarajan S, Anandaradje A, Shivabasappa S, et al | PROSPERO
|
|
|
4/22/21
|
Huang K, Lou S | PROSPERO
|
|
|
4/22/21
|
Van Dusen R, Abernethy K, Kurmi O | PROSPERO
|
|
|
4/22/21
|
Scquizzato T, D'Amico F, Rocchi M, et al | PROSPERO
|
|
|
4/22/21
|
Zhang P, Harnegie MP, Alwakeel M, et al | PROSPERO
|
|
|
4/22/21
|
Molena KF, Pacheco JA, Gontijo CRO, et al | PROSPERO
|
|
|
4/22/21
|
Nascimento L, Fregonezi G, Torre-Castro R, et al | PROSPERO
|
|
|
4/22/21
|
XiaLi X, Zhongyi D, Ning L, et al | PROSPERO
|
|
|
4/22/21
|
Hajissa K, Islam A, Mohamed Z, et al | PROSPERO
|
|
|
4/22/21
|
Gan L, Tan J, Zhang D | PROSPERO
|
|
|
4/22/21
|
Pong J, Frengopoulos C | PROSPERO
|
|
|
4/21/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/21/21
|
Fazzini b, Puthucheary Z, Page A | PROSPERO
|
|
|
4/21/21
|
de Barros Gonze B, di Paschoale Ostolin TLV | PROSPERO
|
|
|
4/21/21
|
Wadnerkar-Kamble M, Campbell R, Curran E, et al | PROSPERO
|
|
|
4/21/21
|
Bacaro V, Meneo D, Martoni M, et al | PROSPERO
|
|
|
4/20/21
|
Moura S, Oliveira R, Cruz L, et al | PROSPERO
|
|
|
4/20/21
|
Khawaja A, Ali R, Ather M, Kim M, et al | PROSPERO
|
|
|
4/20/21
|
Gama RKB, de Oliveira MML, dos Santos ACM, et al | PROSPERO
|
|
|
4/20/21
|
Wu Y, Zhang G, | PROSPERO
|
|
|
4/20/21
|
Fan M, Guo D, Zhao J | PROSPERO
|
|
|
4/20/21
|
Meena JP, Gupta AK, Haldar P | PROSPERO
|
|
|
4/20/21
|
Meena JP, Gupta AK, Haldar P | PROSPERO
|
|
|
4/20/21
|
Moreira DC, Dieter C, Lemos NE, et al | PROSPERO
|
|
|
4/20/21
|
Tan R, Chua EX, Hasan S, et al | PROSPERO
|
|
|
4/20/21
|
Moniz M, Pereira S, Leite A | PROSPERO
|
|
|
4/20/21
|
Hamada Y, Rangaka M, Papineni P, et al | PROSPERO
|
|
|
4/20/21
|
Chen J, Farah N, Dong RK, et al. | medRxiv
Aim: To provide a systematic review and meta-analysis on the prevalence rates of mental health symptoms of anxiety, depression, and insomnia among the major populations during the COVID-19 pandemic in Africa.
|
|
|
4/19/21
|
Singh AK, Kumar A, Sharma M, et al | PROSPERO
|
|
|
4/19/21
|
Zhang S, Qin X, Tan B, et al | PROSPERO
|
|
|
4/19/21
|
Carcaillon-Bentata L, Makovski T, Ghattas J, et al | PROSPERO
|
|
|
4/19/21
|
Miles B, Saville C | PROSPERO
|
|
|
4/19/21
|
England R, Kumar E, Zohoori V, et al | PROSPERO
|
|
|
4/19/21
|
Betthaeuser BA, Bach-Mortensen AM, Engzell P | PROSPERO
|
|
|
4/19/21
|
Shah V, Binnicker M, Yao J, et al | PROSPERO
|
|
|
4/19/21
|
Urši? A, Kukec A, Vracko P | PROSPERO
|
|
|
4/19/21
|
Wei H, Li S, O'Toole T, Yu M, et al | PROSPERO
|
|
|
4/19/21
|
Uribe ES, Mancías Guerra CM, Canales NG, et al | PROSPERO
|
|
|
4/19/21
|
Alqahtani J, Oyelade T, Hurst J | PROSPERO
|
|
|
4/19/21
|
Leary LO, Moran F, Kiely D | PROSPERO
|
|
|
4/19/21
|
Wang H, Jiang H, Zhao J, et al | PROSPERO
|
|
|
4/19/21
|
Fei Z, Chen Z, Du X, et al | PROSPERO
|
|
|
4/19/21
|
Patwary MM, Alam A, Shuvo FK | PROSPERO
|
|
|
4/19/21
|
Santos M, Silva C, Lyra R | PROSPERO
|
|
|
4/19/21
|
Tuina (massage) therapy for insomnia in COVID-19: a protocol for systematic review and meta-analysis
Meng M, Hu G, Yang K, et al | PROSPERO
|
|
|
4/18/21
|
Miniati M , Marzetti F, Palagini L, et al | medRxiv
Aim: To summarize present literature on COVID pandemic and eating disorders.
|
|
|
4/16/21
|
Chong W, Saha B | PROSPERO
|
|
|
4/16/21
|
Alsaif F, Wright D, Patel A, et al. | PROSPERO
|
|
|
4/16/21
|
Martha J, Pranata R, Lim M | PROSPERO
|
|
|
4/16/21
|
Shahhosseini Z, Hajimohammadreza M, Mohammadi KM, et al. | PROSPERO
|
|
|
4/16/21
|
Motlagh RS, Abufaraj M, Karakiewicz P, et al. | PROSPERO
|
|
|
4/16/21
|
Li H, Yang J, Yan B | PROSPERO
|
|
|
4/16/21
|
Edington F, Gadelha S, Santiago M, et al. | PROSPERO
|
|
|
4/16/21
|
Calderon DA, Suen HYG | PROSPERO
|
|
|
4/16/21
|
Fowler K, Robbins L | PROSPERO
|
|
|
4/16/21
|
Hernandez-Garn M, Erlacher V, Mezes B | PROSPERO
|
|
|
4/16/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/16/21
|
Al-Nabahin A, Drid B, Alagelli F, et al. | PROSPERO
|
|
|
4/16/21
|
Kotlar B, Rolnik D, Denduluri A, Mark T, et al. | PROSPERO
|
|
|
4/16/21
|
Cordoves RA, Rivera K | PROSPERO
|
|
|
4/15/21
|
Chen J, Zhang SX, Xu W, et al. | medRxiv
Aim: To review and assess the prevalence of anxiety, depression, and insomnia symptoms in the general population, frontline healthcare workers (HCWs), and adult students in Spain during the COVID-19 crisis. UPDATED
|
|
|
4/15/21
|
Alharbi M, Alharbi A | PROSPERO
|
|
|
4/15/21
|
Ponsford M, Ward TJC, Stoneham S, et al | PROSPERO
|
|
|
4/15/21
|
Vieira CC, da Donseca Orcina B, Brito Reia VC, da Silva Santos PS | PROSPERO
|
|
|
4/15/21
|
Sarkar PG, Kumar A | PROSPERO
|
|
|
4/15/21
|
Alfonso-Castillo G, Pinoti R | PROSPERO
|
|
|
4/15/21
|
Deng H, Yan X, Yuan L, et al | PROSPERO
|
|
|
4/15/21
|
Batra K, Batra R, Sharma M, et al | PROSPERO
|
|
|
4/15/21
|
Pickford R, Woeckel M, Schneider A, et al | PROSPERO
|
|
|
4/15/21
|
Giebel C, Talbot C, Thyrian JR, et al | PROSPERO
|
|
|
4/15/21
|
Cui H, He H, Fan R, et al | PROSPERO
|
|
|
4/15/21
|
Souza KS, da Silva MRF, de Pinto Brito B, Ferreira Rocha FL, et al | PROSPERO
|
|
|
4/14/21
|
Peña R, Osorip C | PROSPERO
|
|
|
4/14/21
|
Zheng Y, Wang L, Zhu Y, et al. | Medicine
|
|
|
4/14/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
4/14/21
|
Wang X, Wang Y, Liang L | Medicine
|
|
|
4/13/21
|
Wang YL, Zhang M | PROSPERO
|
|
|
4/13/21
|
Wang J, Su K, Qi L, et al | PROSPERO
|
|
|
4/13/21
|
Rajendran V, Chenna D, Kamdasamy D, et al | PROSPERO
|
|
|
4/13/21
|
Audrey J, Tahapary D | PROSPERO
|
|
|
4/13/21
|
Guo P, Begum T, Efstathiou N, et al | PROSPERO
|
|
|
4/13/21
|
Sebong PH, Pardosi J, Susianto IA, et al | PROSPERO
|
|
|
4/13/21
|
Pan Q, Li M, Jing F, et al | PROSPERO
|
|
|
4/13/21
|
Sakala M, Kambalame DM, Hara H, et al | PROSPERO
|
|
|
4/13/21
|
Wang G, Chen W, Chen X, et al | PROSPERO
|
|
|
4/13/21
|
Gunnarson K, Mathews A, Cao Y, et al | PROSPERO
|
|
|
4/13/21
|
Pal R, Bhadada S | PROSPERO
|
|
|
4/13/21
|
Vásquez AMP, Pérez Delgadillo GM | PROSPERO
|
|
|
4/13/21
|
Tokavanich N, Mongkonsritragoon W | PROSPERO
|
|
|
4/13/21
|
Lima de Sousa E, de Carvalho Saraiva JB, Macedo Santos RS | PROSPERO
|
|
|
4/13/21
|
Kumar A, Munisamy M, Prasad A, et al | PROSPERO
|
|
|
4/13/21
|
Sarkar PG, Kumar A | PROSPERO
|
|
|
4/13/21
|
Zanirati G, Provenzi L, Bizotto S, et al | PROSPERO
|
|
|
4/13/21
|
Heath P, Ikram SI, Sutton N, et al | PROSPERO
|
|
|
4/13/21
|
Woller S, Klok E, de Wit K, et al | PROSPERO
|
|
|
4/13/21
|
Cheng A, Deans R | PROSPERO
|
|
|
4/13/21
|
Hessami K, Shamshirsaz A | PROSPERO
|
|
|
4/12/21
|
Wang Y, Yang X, Chen H, et al. | Medicine
|
|
|
4/12/21
|
Zhour Y, Yan X, Ma F, et al. | Medicine
|
|
|
4/12/21
|
Hoshijima H, Mihara T, Seki H, et al. | medRxiv
Aim: To determine long-term symptoms in COVID-19 survivors after infection. UPDATED
|
|
|
4/9/21
|
Drury J, Mao G, John A, et al. | medRxiv
Aim: To describe public attitudes towards certification, and its possible impact on uptake of testing and vaccination, protective behaviours, and crime.
|
|
|
4/9/21
|
Chong W, Saha B, Medarov B | PROSPERO
|
|
|
4/9/21
|
Chong W, Saha B, Chopra A | PROSPERO
|
|
|
4/9/21
|
Ssentongo AE, Ssentongo P, McCall-Hosenfeld, et al | PROSPERO
|
|
|
4/9/21
|
Melgarejo-Castillo AA, Del Villar MAH, Balarezo PIT, et al | PROSPERO
|
|
|
4/9/21
|
Pranata R, Raffaelo W, Wibowo A | PROSPERO
|
|
|
4/9/21
|
De la Rosa-Martinez D, Delaye-Martínez MA, Juárez-Cruz ID, et al | PROSPERO
|
|
|
4/9/21
|
Kotepui M, Wilairatana P, Masangkay FR, et al | PROSPERO
|
|
|
4/9/21
|
Yusof RC, Noor NM, Yacon MA | PROSPERO
|
|
|
4/9/21
|
Major M, Horton S, Majowicz S, et al | PROSPERO
|
|
|
4/9/21
|
Haji-Hassan M, Bolboaca S, Lenghel M | PROSPERO
|
|
|
4/9/21
|
Pinto L, Schaan B | PROSPERO
|
|
|
4/8/21
|
Tam M, Davis V, Ahluwalia M, et al | PROSPERO
|
|
|
4/8/21
|
Nicholas C, Ng CH | PROSPERO
|
|
|
4/8/21
|
Howard R, Manohar H, Sharma A, et al | PROSPERO
|
|
|
4/8/21
|
Reda RM, Refaat R, Ageeb M, et al | PROSPERO
|
|
|
4/8/21
|
Pino-Zavaleta F, Fernández MF, Vasquez-Ramirez N, et al | PROSPERO
|
|
|
4/8/21
|
Da Silva MS, De Morais Gouveia GP, de Sousa Mesquita Silva E, et al | PROSPERO
|
|
|
4/8/21
|
Nothacker J, Schmucker C, Meerpohl J, et al | PROSPERO
|
|
|
4/8/21
|
Crivelli L, Palmer K, Mangialasche F, et al | PROSPERO
|
|
|
4/8/21
|
Chong W, Saha B | PROSPERO
|
|
|
4/8/21
|
Harapan H, Fahriani M, Fajar JK | PROSPERO
|
|
|
4/8/21
|
Montelo ES, de Sousa Mesquita Silva E, de Sousa FA, et al | PROSPERO
|
|
|
4/8/21
|
Pal R, Bhadada SK | PROSPERO
|
|
|
4/8/21
|
O'Donoghue C, Thomas S, Fleming P, et al | PROSPERO
|
|
|
4/8/21
|
Hahne TM, Brushinski E, Drewitz KP, et al | PROSPERO
|
|
|
4/8/21
|
Antonopoulos V, Theocharis A, Christodoulou N | PROSPERO
|
|
|
4/8/21
|
Sharma B, Agarwal N | PROSPERO
|
|
|
4/8/21
|
Obnial JC, Sia NE, Austria JT, et al | PROSPERO
|
|
|
4/8/21
|
Xiao L, Huang S | PROSPERO
|
|
|
4/8/21
|
Kyriakopoulos C, Gogali A, Kostikas K, et al | PROSPERO
|
|
|
4/7/21
|
Simon A, Adera T, Yilma T, et al | PROSPERO
|
|
|
4/7/21
|
Ernst M, Werner AM, Niederer D | PROSPERO
|
|
|
4/7/21
|
Cevik A, Koroglu CO, Karacam Z, et al | PROSPERO
|
|
|
4/7/21
|
Pranata R, Lim M, Wibowo A | PROSPERO
|
|
|
4/7/21
|
Meggiolaro A, Schepisi MS, Siddu A, et al | PROSPERO
|
|
|
4/7/21
|
Shinejil U, Royce R, Lisa J, et al | PROSPERO
|
|
|
4/7/21
|
Iskandarani G, Koshiaris C, Khamis A, et al | PROSPERO
|
|
|
4/7/21
|
Massoud G, Zouein F, Abdulhai F, et al | PROSPERO
|
|
|
4/7/21
|
Pranata R, Raffaelo W, Wibowo A | PROSPERO
|
|
|
4/7/21
|
Verstraeten R, Touré M, Diatta D, et al | PROSPERO
|
|
|
4/6/21
|
Mackintosh E, Truesdale M | PROSPERO
|
|
|
4/6/21
|
Ebrahimi M, Harmooshi NN, Rahim F | medRxiv
Aim: To assess the diagnostic utility of antigen detection rapid diagnostic tests for covid- 19 versus RT-PCR in a different type of samples and different stages of infection determine the usability of rapid tests in best time and sample.
|
|
|
4/6/21
|
Shaikh SZ, Patil A, Langde D | PROSPERO
|
|
|
4/6/21
|
Elsayed HH, Hassaballa AS, Ahmed TA, et al. | Research Square
Aim: To review the evidence on ECMO for COVID-associated ARDS to study its outcome.
|
|
|
4/6/21
|
Pereira FD, Zaidan P, Rosa G | PROSPERO
|
|
|
4/6/21
|
Hur G, Cinar N | PROSPERO
|
|
|
4/5/21
|
Xue X, Deng Z, Li N, et al. | Research Square
|
|
|
4/2/21
|
Wang MX, Gwee SXW, Pang J | Preprints.org
Aim: To systematically assess the associations between micronutrient supplementation or deficiency, with novel coronavirus incidence and disease severity.
|
|
|
4/1/21
|
Le H, Pham T | PROSPERO
|
|
|
4/1/21
|
Murphy A, Kirby A, Drummond F, et al | PROSPERO
|
|
|
4/1/21
|
Cui Y, Li S, Yang Z, et al | PROSPERO
|
|
|
4/1/21
|
Arago G, Soares D, Soares E | PROSPERO
|
|
|
4/1/21
|
Jiao B, Cavayas A, Williamson D, et al | PROSPERO
|
|
|
4/1/21
|
Sin J, Chien WT, Batchelor R, et al | PROSPERO
|
|
|
4/1/21
|
Chen MS, Chen RK, Zheng ZZ, et al | PROSPERO
|
|
|
4/1/21
|
Ung L, Goss D, Hanage W | PROSPERO
|
|
|
4/1/21
|
Wang L, Huang L | PROSPERO
|
|
|
4/1/21
|
Prosperini L, Haggiag S, Totorella C, et al | PROSPERO
|
|
|
4/1/21
|
Bitencourt FV, Lia EN, Pauletto P, et al | PROSPERO
|
|
|
4/1/21
|
Karacam Z, Sari E, Yüksel R, Arslanta? H | PROSPERO
|
|
|
4/1/21
|
Wishnuwardhana, Fernandez | PROSPERO
|
|
|
3/31/21
|
Banholzer N, Lison A, Özcelik D, et al | PROSPERO
|
|
|
3/31/21
|
Gonçalves AK, Rodrigues HM, Medeiros K, et al | PROSPERO
|
|
|
3/31/21
|
Boland L, Garcia AJ, Aylward E, et al | PROSPERO
|
|
|
3/31/21
|
Marques T, Cuoto P | PROSPERO
|
|
|
3/31/21
|
Shi C, Wu M | PROSPERO
|
|
|
3/31/21
|
Ozdemir K, Baskaya Y, Sahin S | PROSPERO
|
|
|
3/31/21
|
Ferrari A, Santomauro D, Mantilla-Herrera A, et al | PROSPERO
|
|
|
3/31/21
|
Frank J, Herchenhahn C, Wedekind L, et al | PROSPERO
|
|
|
3/31/21
|
Servais C, De Breuck Y | PROSPERO
|
|
|
3/30/21
|
Clark S, Vindrola C | PROSPERO
|
|
|
3/30/21
|
Sasikumar A, Iype T, Anish T S, et al | PROSPERO
|
|
|
3/30/21
|
Marczak J, Velickovic S, Neddermeyer A, et al | PROSPERO
|
|
|
3/30/21
|
Li J, Liao X, Zhou Y, et al. | Research Square
Aim: To evaluate this potential effect from glucocorticoids treatment for COVID-19.
|
|
|
3/30/21
|
Aragão G, Oliveira S, Moita S | PROSPERO
|
|
|
3/30/21
|
Goncalves AK, Medeiros KS, Macêdo LTA, et al | PROSPERO
|
|
|
3/30/21
|
Gao M, Wang M | PROSPERO
|
|
|
3/30/21
|
Qin X, Teng X, Liu Y, Meichao S, et al | PROSPERO
|
|
|
3/30/21
|
Yang Y, Fang M | PROSPERO
|
|
|
3/30/21
|
Budd G, Griffiths D, Howick J, et al | PROSPERO
|
|
|
3/30/21
|
Kharel M, Sakamoto JL, Carandang RR, et al | PROSPERO
|
|
|
3/30/21
|
Watts T, Anstey S, Bundy C, et al | PROSPERO
|
|
|
3/30/21
|
de Santos LR, Martin MAF | PROSPERO
|
|
|
3/30/21
|
Tashakori-Miyanroudi, Souresafil A, et al | PROSPERO
|
|
|
3/30/21
|
Aggarwal AN, Agarwal R, Dhooria S, et al | PROSPERO
|
|
|
3/30/21
|
Susanti HD, Chung MH | PROSPERO
|
|
|
3/30/21
|
Hickey S, Di Nota P | PROSPERO
|
|
|
3/30/21
|
Burns KEA, Cook D, Rochwerg B, et al | PROSPERO
|
|
|
3/30/21
|
Odonnell J, Pirret A, Hoare K | PROSPERO
|
|
|
3/30/21
|
Du C, Chen B, Ao N, et al | PROSPERO
|
|
|
3/30/21
|
Viana de Sousa NC, da Silva J, de Souza Godinho | PROSPERO
|
|
|
3/29/21
|
Daniels S, Wei H, Denning D, et al | PROSPERO
|
|
|
3/29/21
|
Wang J, Kaperak C, Sato T, et al. | medRxiv
Aim: To identify cases infected with different genetic strains of SARS-CoV-2 confirmed by polymerase-chain reaction and viral genome sequencing.
|
|
|
3/29/21
|
Wong C, Li B, Quon B | PROSPERO
|
|
|
3/29/21
|
Ali S, Uddin SZ, Dewan MN, et al. | medRxiv
Aim: To investigate the effect of corticosteroids on the mortality of patients with respiratory viral infections including SARS-CoV-2, SARS, MERS, and Influenza.
|
|
|
3/29/21
|
Zhao J, Guo D, Fan M | PROSPERO
|
|
|
3/29/21
|
Bignardi PR, Castello PA, Aquino BM, et al. | medRxiv
Aim: To assess a possible association between plasma vitamin D levels and mortality in patients with COVID–19.
|
|
|
3/29/21
|
Vásquez AAH, Barrenechea-Pulache A, Comande D, et al. | medRxiv
Aim: To conduct a living systematic review of the clinical evidence regarding the effect of different mouth?rinses on the viral load of SARS?CoV?2 in the saliva of infected patients. UPDATED
|
|
|
3/29/21
|
Bhujel N, Zaheer K, Singh RP | PROSPERO
|
|
|
3/29/21
|
Heneghan CJ, Spencer EA, Brassey J, et al. | F1000Res
Aim: To identify, appraise and summarise the evidence from studies of the role of airborne transmission of SARS-CoV-2
|
|
|
3/29/21
|
Onakpoya IJ, Heneghan CJ, Spencer EA, et al. | F1000Res
Aim: To identify, appraise and summarise the evidence from primary studies and systematic reviews assessing the role of fomites in transmission.
|
|
|
3/29/21
|
Diana L, Zanin E, Bonato M, et al | PROSPERO
|
|
|
3/29/21
|
Donoghue K, Pilling S, Saunders R | PROSPERO
|
|
|
3/26/21
|
Li X, Lu H, Li F, et al | PROSPERO
|
|
|
3/26/21
|
Salem N, Ftouni R, Al Jardali B, et al | PROSPERO
|
|
|
3/26/21
|
Guo Q, Wang J, Wu S, et al | PROSPERO
|
|
|
3/26/21
|
Lau V, Mah G, Odenbach J, et al | PROSPERO
|
|
|
3/26/21
|
Yang D, Tao S, Chen Y, et al | PROSPERO
|
|
|
3/26/21
|
Ju J, Yan C, Wang H, et al. | Medicine
|
|
|
3/26/21
|
Song B, Hu Y | PROSPERO
|
|
|
3/26/21
|
Chavan SA, Al-Zumair M, Maxwell L | PROSPERO
|
|
|
3/26/21
|
Aragao G, Neto OB, Britto D, et al | PROSPERO
|
|
|
3/26/21
|
Mihelcic G, Kukec A, Klanš?ek HJ | PROSPERO
|
|
|
3/26/21
|
Yasuda H, Mayumi T, Okano H | PROSPERO
|
|
|
3/26/21
|
Kumar A, Khan S, Rai A, et al | PROSPERO
|
|
|
3/26/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
3/26/21
|
Ali D, Bundy R, Mandy W | PROSPERO
|
|
|
3/26/21
|
Zhong M, Huang W, Tang G, et al | PROSPERO
|
|
|
3/26/21
|
Ling R, Tan WQ, Wen Yeo LH, et al | PROSPERO
|
|
|
3/25/21
|
Zang S, Zhao YH, Chang Q, et al | PROSPERO
|
|
|
3/25/21
|
Joshi R, Khan MA | PROSPERO
|
|
|
3/25/21
|
Thakar A, Goyal M, Panara K, et al | PROSPERO
|
|
|
3/25/21
|
Mahmoudi E, Keykhaei M | PROSPERO
|
|
|
3/25/21
|
Urbina C, Chumpitaz CP, Torres-Slimming P | PROSPERO
|
|
|
3/25/21
|
Kong G, Lim NA, Chin YH | PROSPERO
|
|
|
3/25/21
|
Chen J, Cai Y, Zeng J, et al | PROSPERO
|
|
|
3/25/21
|
de Rivera PC, Barajas A | PROSPERO
|
|
|
3/24/21
|
Crankson S, Pokhrel S, Anokye NK | medRxiv
Aim: To investigate what factors determined the mortality and length of hospitalisation in individuals with COVID-19.
|
|
|
3/24/21
|
Charreau S, Wormser J, Philippart F | PROSPERO
|
|
|
3/24/21
|
Hosseini MS, Akbarzadeh MA, Vaez-Gharamaleki Y, et al | PROSPERO
|
|
|
3/24/21
|
Vindrola-Padros C, Singh K, Sidhu MS, et al. | medRxiv
Aim: To analyse the implementation and impact of remote home monitoring models (virtual wards) during COVID-19, identifying their main components, processes of implementation, target patient populations, impact on outcomes, costs and lessons learnt. UPDATED
|
|
|
3/24/21
|
Weston O, Rankin J, Dyer J, et al | PROSPERO
|
|
|
3/23/21
|
Rodrigues P, Tibolla Viero F, Tiollier Weber E, et al | PROSPERO
|
|
|
3/23/21
|
BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review
 Stack M, Sacco K, Castagnoli R, et al. | Research Square
Aim: To evaluate the use of BTK inhibitors (BTKinibs) during COVID-19 and assess how they may affect patient outcomes.
|
|
|
3/23/21
|
Wang X, Yin X | PROSPERO
|
|
|
3/23/21
|
Prakash K, Kumar N, Verma S, et al | PROSPERO
|
|
|
3/23/21
|
Khushnood K, Sultan N, Altaf S | PROSPERO
|
|
|
3/23/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
3/23/21
|
Matli K, Farah R, Maalouf M, et al. | medRxiv
Aim: To highlight the role of thrombosis in COVID-19 and provide new insights on the use of antithrombotic therapy in its management.
|
|
|
3/23/21
|
Liu J, Wang R, Tao L | PROSPERO
|
|
|
3/23/21
|
Kang Y, Li X, Wei W, et al | PROSPERO
|
|
|
3/23/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
3/23/21
|
Khalil C, Soni V, Englesakis M, et al | PROSPERO
|
|
|
3/22/21
|
Espinoza-Espinoza DA, Dulanto-Vargas JA, Caceres-La Torre OA, et al | PROSPERO
|
|
|
3/22/21
|
Perroud J, Soldano S, Avanseña A, et al | PROSPERO
|
|
|
3/22/21
|
Dhada S, Stewart D, Cheema E, et al. | medRxiv
Aim: To examine patients’ and caregivers’ experiences of accessing cancer services during the COVID-19 pandemic and perceived impact of the pandemic on their psychological wellbeing. UPDATED
|
|
|
3/22/21
|
Debela D, Heraro K | medRxiv
|
|
|
3/22/21
|
Silverii GA, Dicembrini I, Mannucci E, et al | PROSPERO
|
|
|
3/22/21
|
McGing RM, Perinpanathan T, Barlow G, et al | PROSPERO
|
|
|
3/22/21
|
Zhao J, Guo D, Liu Y | PROSPERO
|
|
|
3/22/21
|
Viero FT, Rodrigues P, Kudsi SQ, et al | PROSPERO
|
|
|
3/22/21
|
Viero FT, Rodrigues P, Waldraff H, et al | PROSPERO
|
|
|
3/22/21
|
Letourneau N, Leite F, Hayden A, et al | PROSPERO
|
|
|
3/22/21
|
Toubasi A, Alsayegh T, Obaid Y, et al | PROSPERO
|
|
|
3/22/21
|
Gonçalves AK, Medeiros K, Costa APF, et al | PROSPERO
|
|
|
3/22/21
|
Hu P, Zhang D, Zhu Y, et al | PROSPERO
|
|
|
3/22/21
|
Nash N, Whittle C, Whitmarsh L, et al | PROSPERO
|
|
|
3/22/21
|
Suarez-Gonzalez A, Rajagopalan J, Livingston G, et al. | medRxiv
Aim: To examine and summarise the global research evidence describing the effect of Covid-19 isolation measures on the health of people living with dementia. UPDATED
|
|
|
3/22/21
|
Morales MB, Ortiz-Munoz L, Anselmi GD, et al. | Health Sci Rep
|
|
|
3/19/21
|
Sun Y, Cui Y | PROSPERO
|
|
|
3/19/21
|
Wiens A, Tonin FS, Leonart LP, et al | PROSPERO
|
|
|
3/19/21
|
Rayanakorn A, Chaiprom P, Huey Lee SW | PROSPERO
|
|
|
3/19/21
|
Banh HL, Hu Y, Kung J, et al | PROSPERO
|
|
|
3/19/21
|
Tolton R, Langley T, Bastounis A | PROSPERO
|
|
|
3/19/21
|
Ivermectin for Prevention and Treatment of COVID-19 Infection: a Systematic Review and Meta-analysis
Bryant A, Lawrie TA, Dowswell T, et al. | Research Square
Aim: To assess the efficacy of ivermectin treatment among people with covid-19 infection and as a prophylaxis among people at higher risk of covid-19 infection.
|
|
|
3/19/21
|
Stroehlein J, Griesel M, Popp M, et al | PROSPERO
|
|
|
3/19/21
|
Ningning Y, Fuhai W | PROSPERO
|
|
|
3/19/21
|
Raimundo R, da Assunção Morais e Cunha Vaz Patto M, Pinto | PROSPERO
|
|
|
3/19/21
|
Teixeira K, Lisboa J, Ferreira R, et al | PROSPERO
|
|
|
3/19/21
|
Højberg AM, Henriksen TB, Gjerløv AS | PROSPERO
|
|
|
3/19/21
|
Nunes MJM, Araújo DP | PROSPERO
|
|
|
3/19/21
|
Zhang K, Zhang G | PROSPERO
|
|
|
3/18/21
|
Pejman A, Aghaei L, Salajeghe T, et al | PROSPERO
|
|
|
3/18/21
|
Billings J, Ching BCF, Gkofa V, et al. | medRxiv
Aim: To review the evidence on the experiences of frontline healthcare workers and their views about psychosocial support during the COVID-19 or comparable pandemics.
|
|
|
3/18/21
|
Scquizzato T, Landoni G, Zangrillo A | PROSPERO
|
|
|
3/18/21
|
Galvis LMR, Carcamo SP, Ocampo SS, Lopez AS, et al | PROSPERO
|
|
|
3/18/21
|
Ruvinsky S, Voto C, Fustiñana A, et al | PROSPERO
|
|
|
3/18/21
|
Fabbri L, Moss S, Khan F, et al. | medRxiv
Aim: To assess the prevalence of long term radiological and functional pulmonary sequelae in survivors from COVID-19 and other viral pneumonia in published literature. UPDATED
|
|
|
3/18/21
|
Sampaio L, Medrado A | PROSPERO
|
|
|
3/18/21
|
Ding Y, Guo C, Yu S, et al. | Medicine
|
|
|
3/18/21
|
Hannah J, Galloway J, Bechman K, et al | PROSPERO
|
|
|
3/18/21
|
Jie AJ, Doshi K, Sultana R, et al | PROSPERO
|
|
|
3/18/21
|
Aletreby WT, Abdulrahman B, Mady AF, et al. | medRxiv
Aim: To perform a systematic literature review and meta-analysis of RCTs utilizing Tocilizumab in the treatment of COVID 19 pneumonia, with in hospital mortality as a primary objective, while secondary objectives included composite outcome of mortality, intubation, or ICU admission, another secondary outcome was super added infection.
|
|
|
3/18/21
|
Viner R, Waddington C | PROSPERO
|
|
|
3/18/21
|
Banh HL, Hu Y, Kung J, et al | PROSPERO
|
|
|
3/18/21
|
Grady M, Hayton C, Meyrick J, | PROSPERO
|
|
|
3/16/21
|
Li GF, Yu G, An XX, et al | PROSPERO
|
|
|
3/16/21
|
Ahmed B, Yousaf Z, Ata F, et al | PROSPERO
|
|
|
3/16/21
|
Cruciani M, Pati I, Maimone P, et al | PROSPERO
|
|
|
3/16/21
|
Martins J, Lucchetta R, Mastroianni P | PROSPERO
|
|
|
3/16/21
|
Beck R, Brennan T, Tarantino G, et al | PROSPERO
|
|
|
3/16/21
|
Zhao-chen JI, Hu Hy, Jun-hua Z, et al | PROSPERO
|
|
|
3/16/21
|
Sharma R, Sharma R | PROSPERO
|
|
|
3/16/21
|
Mariano L, Monteiro LM, André L | PROSPERO
|
|
|
3/16/21
|
Fisher J, Chang YS, Winn L, et al | PROSPERO
|
|
|
3/16/21
|
Hussain B, Latif A, Timmons S, et al | PROSPERO
|
|
|
3/16/21
|
Yang Z, Zhang S | PROSPERO
|
|
|
3/16/21
|
Tong ZX, Hui L, Ming HS | PROSPERO
|
|
|
3/16/21
|
XuTong Z, Tian LT, Hui L | PROSPERO
|
|
|
3/16/21
|
Damara F, Soetedjo N | PROSPERO
|
|
|
3/16/21
|
Wardani Y, Santri IN, Sustani EW, et al | PROSPERO
|
|
|
3/16/21
|
Kan C, Sun X, Hou N, et al | PROSPERO
|
|
|
3/16/21
|
García VS, Rincón JMR | PROSPERO
|
|
|
3/16/21
|
Ghulam A, Gianfagna F, Bonaccio M, et al | PROSPERO
|
|
|
3/16/21
|
Shankar A, Agustina R, Rianda D, et al | PROSPERO
|
|
|
3/16/21
|
Maraqa B, Nazzal Z, Al Hroub T, Abu Alia W, et al | PROSPERO
|
|
|
3/16/21
|
Grieve K, McClatchey K, Jackson T | PROSPERO
|
|
|
3/15/21
|
Karki R, Annane D, Paoletti X, et al | PROSPERO
|
|
|
3/15/21
|
Tan RQ, Li WTV, Shum W, et al. | Syst Rev
|
|
|
3/15/21
|
Elshenawy RA, Aslanpour Z, Umaru N | PROSPERO
|
|
|
3/15/21
|
Thomas C, Williams L, Dhandapani A, et al | PROSPERO
|
|
|
3/15/21
|
Rottler M, Leiner T, Virag M, et al | PROSPERO
|
|
|
3/15/21
|
Lou L, Zhang H, Tang B, et al. | medRxiv
Aim: To conduct a comprehensive systematic evaluation and meta-analysis of the clinical characteristics of COVID-19 in children and adolescents to better guide the response to the current epidemic.
|
|
|
3/15/21
|
Broger T, Dekinger CM, Olaru ID, et al | PROSPERO
|
|
|
3/15/21
|
Neldi V, Yulistiani Y, Suprapti B, et al | PROSPERO
|
|
|
3/15/21
|
Middleton S, McKeever TM, Bolton CE | PROSPERO
|
|
|
3/15/21
|
Liu CY, Berlin J, Kiti MC, et al. | medRxiv
Aim: To synthesize empirical data on the changing social contact patterns during the COVID-19 pandemic.
|
|
|
3/15/21
|
Tao Z, Cheng B, Zhou T | PROSPERO
|
|
|
3/15/21
|
Mahboob A, Onwumeh-Okwundu JD, Khan R, et al | PROSPERO
|
|
|
3/15/21
|
Lou L, Zhang H, Li Z, et al. | medRxiv
Aim: To evaluate the effect and safety of remdesivir in the treatment of patients with COVID-19, and will provide a reliable reference for the treatment of COVID-19.
|
|
|
3/15/21
|
Celik I, Bektas M, Duran S | PROSPERO
|
|
|
3/15/21
|
Indarto F, Koerniawan HS, Limas PI | PROSPERO
|
|
|
3/15/21
|
Saleki K, Pourahmad R, Yaribash S, et al | PROSPERO
|
|
|
3/15/21
|
Hannemann K, Abdalrahman A, Albus C | PROSPERO
|
|
|
3/15/21
|
Ziegler E, Rietkoetter S, Bryant-Lukosius D, et al | PROSPERO
|
|
|
3/12/21
|
Muthuka J, Muchiri F, Ngeno L | PROSPERO
|
|
|
3/12/21
|
Antunes ML, Couto P, Marques T, et al | PROSPERO
|
|
|
3/12/21
|
Mahat RK, Rathore V, Swain S, Panda S, et al | PROSPERO
|
|
|
3/12/21
|
Perez-Lopez FR, Pérez-Roncero G, López-Baena M | PROSPERO
|
|
|
3/12/21
|
Harapan H, Fahriani M, Fajar JK, et al | PROSPERO
|
|
|
3/12/21
|
Li Z, Yin M, Xu T, et al | PROSPERO
|
|
|
3/12/21
|
Estenson L, Kim N, Jacobson M, et al | PROSPERO
|
|
|
3/12/21
|
Larson EA, Bader-Larsen K, Magkos F | PROSPERO
|
|
|
3/11/21
|
Viero FT, Rodrigues P, Mazzochi N, et al | PROSPERO
|
|
|
3/11/21
|
Shellenberger R, Mayo M, Potugari B, et al | PROSPERO
|
|
|
3/11/21
|
Tavares-Junior JW, Braga-Neto P, de Souza ACC, et al | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Zeng L, Yang K, Chen H | PROSPERO
|
|
|
3/11/21
|
Yang F, Li J, Huang W | PROSPERO
|
|
|
3/11/21
|
Zhang Q, Huang J, Liu X, et al | PROSPERO
|
|
|
3/11/21
|
da Silva Magalhães, Nascimento Maniçoba ACB | PROSPERO
|
|
|
3/11/21
|
Li F, Liang W, Yi L, | PROSPERO
|
|
|
3/11/21
|
Cannarella R, Calogero AE, Crafa A, et al | PROSPERO
|
|
|
3/11/21
|
Li Y, Yang M, Wei S | PROSPERO
|
|
|
3/11/21
|
Wu B, Tao S, Lu Y | PROSPERO
|
|
|
3/11/21
|
Liang H, Song Z, Yuan H | PROSPERO
|
|
|
3/11/21
|
Julianty SA, Anggriani A, Habibe H, et al | PROSPERO
|
|
|
3/11/21
|
Karki SJ, Lange B, Heinsohn T, Joachim A | PROSPERO
|
|
|
3/10/21
|
Alizadeh-Navaei R, Golpur M, Valadan R, et al. | Research Square
Aim: To assess the co-infection of SARS-CoV-2 with influenza among COVID-19 cases.
|
|
|
3/10/21
|
Gesaka R, Ombimbo M | PROSPERO
|
|
|
3/10/21
|
Gao Y, Zhang Z, Cui H | PROSPERO
|
|
|
3/10/21
|
Zhang P, Xie L, Gong J | PROSPERO
|
|
|
3/10/21
|
Lu Y, Wu S, Wu B | PROSPERO
|
|
|
3/10/21
|
Li J, Huang W, Yang F | PROSPERO
|
|
|
3/10/21
|
Zhou L, Liu T, Meng K | PROSPERO
|
|
|
3/10/21
|
Creavin S, Garg M, Hay A | PROSPERO
|
|
|
3/10/21
|
Boden M, Cohen N, Froelich J, et al. | medRxiv
Aim: To review the evidence on whether mental disorder prevalence: (a) was elevated among populations impacted by coronavirus pandemics (relative to unselected populations reported in the literature), and (b) varied by disorder (undistinguished psychiatric morbidity, anxiety, depressive, posttraumatic stress disorders [PTSD]) and impacted population (community, infected/recovered, healthcare provider, quarantined).
|
|
|
3/10/21
|
Gnoato Zotz TG, Santos A, Kus J, et al | PROSPERO
|
|
|
3/10/21
|
Roveron DL, Gonçalves dos Santos IL, Gonçalves dos Santos JL, et al | PROSPERO
|
|
|
3/10/21
|
Vartha SB, Krishna H, Vishwajeet V, et al | PROSPERO
|
|
|
3/10/21
|
Harries M, Lange B, Dreier M | PROSPERO
|
|
|
3/10/21
|
Sen LT, Valeria M, Tri Indraswari M | PROSPERO
|
|
|
3/10/21
|
Tan M, Blaskova A, Bath S, et al | PROSPERO
|
|
|
3/10/21
|
Wang M, Zhai J, Song Z | PROSPERO
|
|
|
3/10/21
|
Zhu X, Cui J, Xu B | PROSPERO
|
|
|
3/10/21
|
Riches S, Hammond N | PROSPERO
|
|
|
3/9/21
|
Robinson E, Sutin AR, Daly M, et al. | medRxiv
Aim: To quantify the size of the mental health burden associated with the pandemic and how this burden changed over time. UPDATED
|
|
|
3/9/21
|
Wang L, Yang LM | PROSPERO
|
|
|
3/9/21
|
Gupta A, Kovoor J, Ovenden C, et al | PROSPERO
|
|
|
3/9/21
|
Yu X, Du L, Ma Y | PROSPERO
|
|
|
3/9/21
|
Meng L, Wang D, Li M | PROSPERO
|
|
|
3/9/21
|
Gu M, Lu P, Yang X | PROSPERO
|
|
|
3/9/21
|
Yuan H, Song Z, Liang H | PROSPERO
|
|
|
3/9/21
|
Yang M, Li Y, Wei S | PROSPERO
|
|
|
3/9/21
|
Hailat R, Thompson R, Goralski T, et al | PROSPERO
|
|
|
3/9/21
|
Oliveira M, Sudati IP, Konzen VM, et al | PROSPERO
|
|
|
3/9/21
|
Pagotto LEC, Pastore GP | PROSPERO
|
|
|
3/9/21
|
Isayev A, Veleiva N, Luljeta I, et al | PROSPERO
|
|
|
3/9/21
|
Kustanti CY, Yunitri N | PROSPERO
|
|
|
3/9/21
|
Jones J, Damery S, Phillips K, et al | PROSPERO
|
|
|
3/9/21
|
Zahair I, Wickham S, Rose T, et al | PROSPERO
|
|
|
3/9/21
|
Qi X, Ao G, Wang Y, et al | PROSPERO
|
|
|
3/9/21
|
Wei GX, Hao W, Ning L, et al | PROSPERO
|
|
|
3/9/21
|
Sonko I, Susanti HD | PROSPERO
|
|
|
3/8/21
|
Albuqueque J, Alexandrino VP, de Melo Silva CL, et al | PROSPERO
|
|
|
3/8/21
|
Langford B, So M, Leung V, et al | PROSPERO
|
|
|
3/8/21
|
Wei GX, Hao W, Nin L, et al | PROSPERO
|
|
|
3/8/21
|
Walsh S, Chowdhury A, Braithwaite V, et al. | medRxiv
Aim: To summarise observational evidence of the effect of school closures and school reopenings on SARS-CoV-2 community transmission. UPDATED
|
|
|
3/8/21
|
Ng KT, Chua EX, Teoh WY, et al | PROSPERO
|
|
|
3/8/21
|
Zhang S, Chen Zl | PROSPERO
|
|
|
3/8/21
|
Deng J, Zhou F, Hou W, et al | PROSPERO
|
|
|
3/8/21
|
Robinson R, Prakash V, Al Tamimi R, et al. | medRxiv
Aim: To estimate the association of remdesivir therapy compared to the usual care or placebo on all-cause mortality in hospitalized patients with COVID-19.
|
|
|
3/8/21
|
Mangoni A, Zineullu | PROSPERO
|
|
|
3/8/21
|
Feliciano-Alfonso JE, Buendia Rodriguez JA, et al | PROSPERO
|
|
|
3/8/21
|
Alharbi AO, Alzerwi NAN, Idrees B | PROSPERO
|
|
|
3/8/21
|
Wei GX, Hao W, Ning L, et al | PROSPERO
|
|
|
3/8/21
|
Parkinson E, Hooper L, Poland F, et al | PROSPERO
|
|
|
3/8/21
|
Carvalho AMS, Vale MS | PROSPERO
|
|
|
3/8/21
|
Zhang Y, Mei T, Chen Y, et al. | Medicine
|
|
|
3/8/21
|
Zhang Q, Lu H, Li F, et al. | Medicine
|
|
|
3/8/21
|
Samaan MC, Rajan R, Kshatriya M, et al | PROSPERO
|
|
|
3/8/21
|
Song G, Wei-Qiao, Yu X | PROSPERO
|
|
|
3/8/21
|
Clark R, Pearce-Smith N, Duval D | PROSPERO
|
|
|
3/5/21
|
Vaughan M, Trott M, Sapkota R, et al | PROSPERO
|
|
|
3/5/21
|
Köhler F, Wiegering A | PROSPERO
|
|
|
3/5/21
|
Uaprasert N, Tangcheewinsirkul N, Chiasakul T | PROSPERO
|
|
|
3/5/21
|
Wan Mohd Yunus WMA, Kauhanen L, Gyllenberg D, et al | PROSPERO
|
|
|
3/5/21
|
Ma S, Sun C, Qu G, et al | PROSPERO
|
|
|
3/5/21
|
Ruksakulpiwat S, Zhou W, Phianhasin L, et al | PROSPERO
|
|
|
3/5/21
|
Kirkovski A, Meyer-Katz G | PROSPERO
|
|
|
3/5/21
|
Kruse C, Atamosa L , Collins A, et al | PROSPERO
|
|
|
3/5/21
|
Nie X, Chen J, Ye F, et al. | Medicine
|
|
|
3/5/21
|
Griswold D, Gempeler A, Kolias A, et al. | BMJ Open
UPDATED
|
|
|
3/5/21
|
Li JW, Liu Y, Zhang ZQ, et al | PROSPERO
|
|
|
3/5/21
|
Zhan Q, Ni Y, Wang Y | PROSPERO
|
|
|
3/5/21
|
Han T, Dong T, Qu G, et al | PROSPERO
|
|
|
3/5/21
|
Kim DK, Kim JH | PROSPERO
|
|
|
3/4/21
|
Ost K, Duquesne L, Duguay C, et al. | medRxiv
Aim: To identify if and how equity has been considered in large-scale testing initiatives.
|
|
|
3/4/21
|
Mathevet I, Ost K, Traverson L, et al. | medRxiv
Aim: To determine if and how health inequities were included in the design of contact tracing interventions in epidemic settings.
|
|
|
3/4/21
|
Miguita L, Rossi NG | PROSPERO
|
|
|
3/4/21
|
Mohammed EE, Ragheb R, Ahmed W, et al | PROSPERO
|
|
|
3/4/21
|
Gary D, Mann J | PROSPERO
|
|
|
3/4/21
|
Sun X, Mazidi M, Kirwan R | Research Square
Aim: To study bidirectional relationships between weight gain, obesity and COVID-19 infection risk during the pandemic.
|
|
|
3/4/21
|
Yan Y, Ren Z, Lai L, et al | PROSPERO
|
|
|
3/4/21
|
Bertuzzi V, Bruno D, Usubini AG, et al | PROSPERO
|
|
|
3/4/21
|
Nyazika T, Ndalama M, Kitui S, et al | PROSPERO
|
|
|
3/4/21
|
Zakia H, Iskandar S | PROSPERO
|
|
|
3/4/21
|
Kim H, Kouyoumdjian F, Cavanagh A, et al | PROSPERO
|
|
|
3/3/21
|
Racine N, Eirich R, Cooke J, et al | PROSPERO
|
|
|
3/3/21
|
Costa FW, Pereira K, Roger A, et al | PROSPERO
|
|
|
3/3/21
|
Pranata R, Lim M, Wibowo A | PROSPERO
|
|
|
3/3/21
|
Popal S, Edekunu G, Osamede A, et al | PROSPERO
|
|
|
3/3/21
|
Loader J, Taylor F, Sundström J | PROSPERO
|
|
|
3/3/21
|
Shao T, Hu Y, Yu W, et al | PROSPERO
|
|
|
3/2/21
|
Assessing the influence of misinformation and disinformation on health information seeking behaviors
McGowan B, Ekeigwe A | PROSPERO
|
|
|
3/2/21
|
Rehman Y, Sachdeca A, Ali P, et al | PROSPERO
|
|
|
3/2/21
|
de Souza Prazeres LP, dos Santos GGP, Veloso FCS, et al | PROSPERO
|
|
|
3/2/21
|
Shao T, Zhou D, Tang W | PROSPERO
|
|
|
3/2/21
|
Li Y, Liu M, Zhang Y, et al | PROSPERO
|
|
|
3/2/21
|
One Year of Evidence on Mental Health in the COVID-19 Crisis - A Systematic Review and Meta-Analysis
Chen X, Chen J, Zhang M, et al. | medRxiv
Aim: To review the evidence on the prevalence rate of mental health issues of the major population, including general population, general healthcare workers (HCWs), and frontline healthcare workers (HCWs), in China over one year of the COVID-19 crisis. UPDATED
|
|
|
3/2/21
|
Shi X, Xiu W, Gang W, et al | PROSPERO
|
|
|
3/2/21
|
Birtles R, Graziadio S, Mealing S, et al | PROSPERO
|
|
|
3/2/21
|
Marchand G, Patil A, Ware K, et al | PROSPERO
|
|
|
3/2/21
|
Brummer LE, Katzenschlager S, Geaddert M, et al. | medRxiv
Aim: To assess the clinical accuracy (sensi-tivity and specificity) of commercially available Ag-RDTs. UPDATED
|
|
|
3/2/21
|
Saragih ID, Saragih IS | PROSPERO
|
|
|
3/2/21
|
Wei GX, Chenyu S, Hao W, et al | PROSPERO
|
|
|
3/2/21
|
Silva A, Maia B, Pinto B, et al | PROSPERO
|
|
|
3/2/21
|
Saragih ID, Saragih IS | PROSPERO
|
|
|
3/1/21
|
Eze P, Agu SA, Agu UJ | PROSPERO
|
|
|
3/1/21
|
Qamar MA, Irfan O, Dhillon RA, et al | PROSPERO
|
|
|
3/1/21
|
Salvador G, Junior EL | PROSPERO
|
|
|
3/1/21
|
Xu J, Ong J, Tran T, et al | PROSPERO
|
|
|
3/1/21
|
Chenchen G, Yi D | PROSPERO
|
|
|
3/1/21
|
Song Q, Guo X, Su W, et al | PROSPERO
|
|
|
3/1/21
|
Hossain M, Hassan S, Gabbay M, et al | PROSPERO
|
|
|
3/1/21
|
Scott E, Finney A, Swaithes L, et al | PROSPERO
|
|
|
3/1/21
|
Li F, Lu H, Zhang Q, et al. | BMJ Open
|
|
|
3/1/21
|
Xu J, Marjia M, Ahluwalia K, et al | PROSPERO
|
|
|
3/1/21
|
Pakzad R, Soltani S, Malekifar P | PROSPERO
|
|
|
3/1/21
|
de Souza TA, da Silva PHA, Galvao MHR, et al. | BMJ Open
|
|
|
3/1/21
|
Xu J, Lio A, Dhaliwal H, et al | PROSPERO
|
|
|
3/1/21
|
Ssentongo P, Chinchilli V, Schiff S, et al | PROSPERO
|
|
|
3/1/21
|
Pranata R, Wibowo A, Lim M | PROSPERO
|
|
|
3/1/21
|
Jagadesh GS, Gavrilids P, Malik S, et al | PROSPERO
|
|
|
3/1/21
|
Gastine S, Pang J, Boshier FAT, et al. | medRxiv
Aim: To describe viral dynamics and estimate the effects of antivirals used to-date.
|
|
|
3/1/21
|
Rogers JP, Watson C, Badenoch J, et al. | medRxiv
Aim: To describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations. UPDATED
|
|
|
3/1/21
|
Liu Y, Liu D, Zhu J, et al | PROSPERO
|
|
|
3/1/21
|
Tabar OA, Ata F, Choudry H, et al | PROSPERO
|
|
|
2/28/21
|
Sauer C, Elbers P, Dam T | PROSPERO
|
|
|
2/28/21
|
Brainin P, Wegener A | PROSPERO
|
|
|
2/28/21
|
Almazroa A, Alamri S, Alabdulkader B, et al | PROSPERO
|
|
|
2/26/21
|
Prattichizzo F, de Candia P | PROSPERO
|
|
|
2/26/21
|
Abdelgawad H, Sharmeen A, Awofeso A, et al | PROSPERO
|
|
|
2/26/21
|
Anju M, Abdulla EK, Velledath SU | PROSPERO
|
|
|
2/26/21
|
Scheckel B, Redaelli M, Lange B, et al | PROSPERO
|
|
|
2/26/21
|
Bezerra P, de Siqueira Barros Nogueira FG, dos Santos AC, et al. | medRxiv
Aim: To evaluate the repercussion of such disease over maternal fetal and neonatal mortality, need for intensive care, way of delivery, premature delivery, birth weight, Apgar score, presence of intrauterine growth restriction (IGR), and presence of amniotic fluid change.
|
|
|
2/26/21
|
Xu N, Lv A, Li X, et al. | BMJ Open
|
|
|
2/26/21
|
Yusuf F, Harapan H, Fahriani M, et al | PROSPERO
|
|
|
2/26/21
|
Ross I, Bick S, Ayieko P, et al | PROSPERO
|
|
|
2/26/21
|
Wolff J, Lange B, Dreier M, et al | PROSPERO
|
|
|
2/26/21
|
Bourmistrova NW, Solomon T, Carter B, et al | PROSPERO
|
|
|
2/26/21
|
Wilke J, Hollander K, Pillay JD, et al | PROSPERO
|
|
|
2/26/21
|
Ansems K, Dahms K, Benstöm K | PROSPERO
|
|
|
2/26/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
2/26/21
|
Mangoni A, Zinellu A | PROSPERO
|
|
|
2/26/21
|
Maraqa B, Nazzal Z, Hroub T, et al | PROSPERO
|
|
|
2/25/21
|
Fomenko A, Weibel S, Moezi H, et al | PROSPERO
|
|
|
2/25/21
|
Xia L, Ramon J, Sha J, et al | PROSPERO
|
|
|
2/25/21
|
Arieta J, Salcedo Alcaychahua AB, Santos GMP, | PROSPERO
|
|
|
2/25/21
|
Calzetta L, Rogliani P | PROSPERO
|
|
|
2/25/21
|
Greenfield S, Damery S, Cartledge S, et al | PROSPERO
|
|
|
2/25/21
|
Blaabjerg J, Behrmann J, Josefine Jordansen, et al | PROSPERO
|
|
|
2/25/21
|
Nna E, Alao M, Anyachukwu C, et al | Research Square
|
|
|
2/25/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/25/21
|
Kamarullah W, Stephanie K, Sabrina AP, et al | PROSPERO
|
|
|
2/25/21
|
David A, Park C | PROSPERO
|
|
|
2/25/21
|
Conde-Agudelo A, Romero R | PROSPERO
|
|
|
2/25/21
|
Yun L, Chen B, Hong Z, et al | PROSPERO
|
|
|
2/25/21
|
Cuevas-Gonzalez JC, Cuevas-Gonzalez MV | PROSPERO
|
|
|
2/25/21
|
Wright T, Keval H, Keys C, et al | PROSPERO
|
|
|
2/25/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
2/25/21
|
Sikhosana N, Fernandez R, Lord H | PROSPERO
|
|
|
2/24/21
|
Vernooij RWM, Pieters T, van Balkom BWM, et al | PROSPERO
|
|
|
2/24/21
|
Viswanatha GL, Male C, Shylaja H | medRxiv
Aim: To evaluate the therapeutic benefits and safety of tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID-19) and associated health complications.
|
|
|
2/24/21
|
Fangfang M, Hewei Z, Mingwei Y, et al | PROSPERO
|
|
|
2/23/21
|
O'Mahoney L, Ekezie W, Pareek M, et al | PROSPERO
|
|
|
2/23/21
|
Xiang HR, Cheng X, Li Y, et al | PROSPERO
|
|
|
2/23/21
|
Kamal A, Ekezie W, Farooqi A, et al | PROSPERO
|
|
|
2/23/21
|
Hao W, Xianwei G, Wangying S, et al | PROSPERO
|
|
|
2/23/21
|
Alasfour M, AlMojel M | PROSPERO
|
|
|
2/23/21
|
Liang Q, Guo X, Su W, Li N, et al | PROSPERO
|
|
|
2/23/21
|
Long Q, Li J, Zheng Y, et al | PROSPERO
|
|
|
2/23/21
|
Rodriguez JG, Guirao E, Benavente A, et al | PROSPERO
|
|
|
2/23/21
|
Richter D, Riedel-Heller SG, Zuercher SJ | medRxiv
Aim: To review the evidence on the course of mental health problems during and after the first lockdown phase of the COVID-19 pandemic. UPDATED
|
|
|
2/23/21
|
Lin Y, Sun T, Yang X, et al | PROSPERO
|
|
|
2/23/21
|
Sahebi A, Golitaleb M | PROSPERO
|
|
|
2/23/21
|
Sutheno A, Pranajaya SB, Sucitra PB | PROSPERO
|
|
|
2/23/21
|
Starke KR, Treskova M, Petereit-Haack G, et al | PROSPERO
|
|
|
2/23/21
|
Mhish O, Tleyjeh IM, Kashour Z, et al | PROSPERO
|
|
|
2/22/21
|
Rycroft C, King-Okoye, Underwood T | PROSPERO
|
|
|
2/22/21
|
Officer A, Pautex S, Broers B | PROSPERO
|
|
|
2/22/21
|
Zawai AT, Naser AY, Alwafi H, et al. | medRxiv
Aim: To evaluate the inflammatory cytokines profile associated with severe human coronavirus diseases, including three stains: MERS-CoV, SARS-CoV SARS-CoV-2, in severe patients. UPDATED
|
|
|
2/22/21
|
Kuikel BS, Dangaura NR, Paneru B | PROSPERO
|
|
|
2/22/21
|
Isaura ER, Paramastri R | PROSPERO
|
|
|
2/22/21
|
Chaharom FE, Nader N | PROSPERO
|
|
|
2/22/21
|
Junior E, Júnior D | PROSPERO
|
|
|
2/22/21
|
Massimi A, Renzi E, Villari P, et al | PROSPERO
|
|
|
2/22/21
|
Marufu D, McGraw C | PROSPERO
|
|
|
2/22/21
|
Luo C, Jin J, He Q | PROSPERO
|
|
|
2/22/21
|
Xiao L, Wen S | PROSPERO
|
|
|
2/22/21
|
Mahmoud M, Mohamed EE, Ragheb R, et al | PROSPERO
|
|
|
2/22/21
|
Fond G, Boyer L, Etchecopar-Etchart D | PROSPERO
|
|
|
2/22/21
|
Mohanty R, Meher BR, Padhy BM, et al. | medRxiv
Aim: To assess the currently available data on the use of colchicine for the treatment of COVID-19. UPDATED
|
|
|
2/22/21
|
Chen PZ, Bobrovitz N, Premji Z, et al. | medRxiv
Aim: To analyze SARS-CoV-2 shedding dynamics across COVID-19 severity, the respiratory tract, sex and age cohorts (aged 0 to 17 years, 18 to 59 years, and 60 years or older).
|
|
|
2/22/21
|
Kremer L, Gutu R, Weyermann M | PROSPERO
|
|
|
2/22/21
|
Rostami A, Sepidarlkish M, Riahi SM, et al | PROSPERO
|
|
|
2/22/21
|
Tortosa F, Carrasco G, Ragusa M, et al. | medRxiv
Aim: To assess the effects of convalescent plasma treatment in patients with coronavirus disease (COVID-19). UPDATED
|
|
|
2/21/21
|
Chaudhuri M, Dhanwal AK | PROSPERO
|
|
|
2/20/21
|
Sohi I, Shield K, Chrystoja B | PROSPERO
|
|
|
2/20/21
|
Daum C, Loggers E, Khaki A | PROSPERO
|
|
|
2/19/21
|
Church K, Hall L | PROSPERO
|
|
|
2/19/21
|
Cong W, Poudel N, Alhusein N, et al. | medRxiv
Aim: To identify studies reporting antimicrobial use in the treatment of hospitalised COVID-19 patients.
|
|
|
2/19/21
|
Yadav K, Ohle R, Lukasik M | PROSPERO
|
|
|
2/19/21
|
Raga D, Salazar AF | PROSPERO
|
|
|
2/19/21
|
Cardenas-Feuntes G, Garcia-Aymerich J, Basea I Gomez M | PROSPERO
|
|
|
2/19/21
|
Abdallah B, Rahman AA, Allam S, et al | PROSPERO
|
|
|
2/19/21
|
Zaffanello M, Prefumo F, Grisolia G, et al | PROSPERO
|
|
|
2/19/21
|
Kirubarajan A, Leung S, Sobel M, et al | PROSPERO
|
|
|
2/19/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/19/21
|
Carvalho I, Marambaia P | PROSPERO
|
|
|
2/18/21
|
Raina R, Chakraborty R, Mawby I, et al | PROSPERO
|
|
|
2/18/21
|
Xia Q, Gao H, Xian J, et al. | Medicine
|
|
|
2/18/21
|
Ghashghaee A, Kan FP, Raoofi S, et al | PROSPERO
|
|
|
2/18/21
|
Naciri A, Radid M, Chemsi G | PROSPERO
|
|
|
2/18/21
|
Seshu PN, Kachroo K, Sharma J | PROSPERO
|
|
|
2/18/21
|
Wang S, Wang J, Wang N | PROSPERO
|
|
|
2/18/21
|
Ekinci G, Çinar F | PROSPERO
|
|
|
2/17/21
|
RM K, Gopalan G, Kachroo K, et al | PROSPERO
|
|
|
2/17/21
|
Farid S, Kamel AM, Sabry N, et al | PROSPERO
|
|
|
2/17/21
|
Hu X, Wang Y, Chen J, et al. | Research Square
Aim: To evaluate the evidence behind claims that Chinese Herbal Medicine, specifically “three medicines and three formulations” (3M3F, comprising Jinhua Qinggan, Lianhua Qingwen, Xuebijing, Qingfei Paidu, Huashi Baidu and Xuanfei Baidu), is an effective treatment for COVID-19.
|
|
|
2/17/21
|
Antony S, Vargese SS, Idikula MJ, et al | PROSPERO
|
|
|
2/17/21
|
Zizzo J, Vicini D | PROSPERO
|
|
|
2/17/21
|
Dong Z, Yang L | PROSPERO
|
|
|
2/17/21
|
AlvesVP, Casemiro FG, Araujo BG, et al. | Preprints
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease. UPDATED
|
|
|
2/17/21
|
Mohd Nordin NR, Arsad FS, Megat Kamaruddin PSN, et al | PROSPERO
|
|
|
2/17/21
|
Dupraz J, Le Pogam MA, Peytremann-Bridevaux I | PROSPERO
|
|
|
2/17/21
|
Colonetti T, da Rosa MI, Ferreira L, et al | PROSPERO
|
|
|
2/17/21
|
Sungur S, Metinta? S, Oktar D, et al | PROSPERO
|
|
|
2/17/21
|
Staibano P, Sommer D, McHugh T | PROSPERO
|
|
|
2/17/21
|
Seaborn K, Chignell M, Gwizdka J | PROSPERO
|
|
|
2/17/21
|
Proulx K, Lenzi-Weisbecker R, Rachel R, et al. | medRxiv
Aim: To review the emerging research on nurturing care for young children during the COVID-19 crisis.
|
|
|
2/17/21
|
Hassanpour S, Arab-Zozani M, Amani B, et al. | medRxiv
Aim: To investigate the efficacy and safety of Favipiravir in the treatment of COVID-19 patients through a systematic review and meta-analysis.
|
|
|
2/17/21
|
Bedoya JPP, Muñoz AM, Barengo NC, et al | PROSPERO
|
|
|
2/16/21
|
Watts K, Alexander E, O'Connor M | PROSPERO
|
|
|
2/16/21
|
Godino L, Gazineo D, Regano D, et al | PROSPERO
|
|
|
2/16/21
|
Blumenfeld O, Miller A, Niv Y, et al | PROSPERO
|
|
|
2/16/21
|
da Silva MDP, Paes LT, de Freitas Rocha AR, et al | PROSPERO
|
|
|
2/16/21
|
de Deus e Mello LM, dos Santos RC, de Albuquerque PC | PROSPERO
|
|
|
2/16/21
|
Nik Hashin NHH, Islam MA, Deris AA, et al | PROSPERO
|
|
|
2/16/21
|
Hannah J, Buazon AD, Galloway J, et al | PROSPERO
|
|
|
2/16/21
|
Viner R, Russell S, Saulle R, et al. | medRxiv
Aim: To review the evidence on the impacts of school closures on the health, wellbeing and educational outcomes of children and young people. UPDATED
|
|
|
2/16/21
|
Ramos K, Laporte L | PROSPERO
|
|
|
2/16/21
|
Yeh PT, Kennedy C, Narasimhan M | PROSPERO
|
|
|
2/16/21
|
Bhanu C, Gopal D, Walters K, et al | PROSPERO
|
|
|
2/16/21
|
Urabe F, Kimura S | PROSPERO
|
|
|
2/16/21
|
Lühnen J, Schmaderer C, PD, et al | PROSPERO
|
|
|
2/16/21
|
Massachi J, Kelly D, Donohue K | PROSPERO
|
|
|
2/16/21
|
Ibrahimi N, Delaunay-Moisan A, Hill C, et al. | medRxiv
Aim: To compare saliva and nasopharyngeal/oropharyngeal samples for the detection of SARS-CoV-2.
|
|
|
2/16/21
|
Bravo P, Fernandez L, Russo M, et al | PROSPERO
|
|
|
2/16/21
|
Duffy N, Whitehall L, Gorska S, Maciver D, et al | PROSPERO
|
|
|
2/16/21
|
Ekinci G, Çinar F | PROSPERO
|
|
|
2/15/21
|
| PROSPERO
|
|
|
2/15/21
|
Sánchez-Velazco DF, Reategui S, Zegarra-Rodríguez CA, et al | PROSPERO
|
|
|
2/15/21
|
Fernandes G, Fernandes J, Couto P | PROSPERO
|
|
|
2/15/21
|
Zaytoun P, Jhinger H, Cannon M | PROSPERO
|
|
|
2/15/21
|
Kurniawan RB, Octaviana DS, Nur Imania HA, et al | PROSPERO
|
|
|
2/15/21
|
Pakzad R, Soltani S, Malekifar P | PROSPERO
|
|
|
2/15/21
|
Hughes MC, Liu Y, Baumbach A | PROSPERO
|
|
|
2/15/21
|
Ganguly U, Mondal R, Deb S, et al | PROSPERO
|
|
|
2/15/21
|
Is there relationship between low body fat and severity of COVID-19 in athletes? A systematic review
Guimarães NS, Fausto MA | PROSPERO
|
|
|
2/15/21
|
Simha S, Bicket M, Ahmed Y | PROSPERO
|
|
|
2/15/21
|
Wright K, Lane D, Bateman L, et al | PROSPERO
|
|
|
2/15/21
|
Chen CH, Wang CY, Lai CC, et al | PROSPERO
|
|
|
2/15/21
|
Sagris D, Florentin M, Ntaios G, et al | PROSPERO
|
|
|
2/12/21
|
Hendrick L, Hickey D | PROSPERO
|
|
|
2/12/21
|
Palmer J, Pearce-Smith N, Duval D, et al | PROSPERO
|
|
|
2/12/21
|
Monteiro AM, Lopes S, Moura C | PROSPERO
|
|
|
2/12/21
|
McGlynn N, Fazli G, Bhatia D, et al | PROSPERO
|
|
|
2/12/21
|
Pecoraro V, Negro A, Trenti T | PROSPERO
|
|
|
2/12/21
|
Kruse C, Heinemann K | PROSPERO
|
|
|
2/12/21
|
Longley B, Nord C, Dalgleish T, et al | PROSPERO
|
|
|
2/12/21
|
Mian A, Cummins C, Shamim I | PROSPERO
|
|
|
2/12/21
|
Prakash J, Khan MS, Tudu LC, et al | PROSPERO
|
|
|
2/12/21
|
Adesanya A, Rankin J, Jessica MR, et al | PROSPERO
|
|
|
2/12/21
|
Tian Y, Lu H, Zhang P, Liu X | PROSPERO
|
|
|
2/12/21
|
McGlynn N, Fazli, Bhatia D, et al | PROSPERO
|
|
|
2/12/21
|
Taype-Rondan A, Hilario-Gomez MM, Quijano-Escate, et al | PROSPERO
|
|
|
2/12/21
|
Funakoshi K, Morita T | PROSPERO
|
|
|
2/11/21
|
van Werkhoven CH, ter Schure J, Bonten MJM, et al | PROSPERO
|
|
|
2/11/21
|
Kite C, Randeva H, Kyrou I, McGregor G, | PROSPERO
|
|
|
2/11/21
|
Ocan M, Kawala BA, Kisangala E, et al. | Research Square
|
|
|
2/11/21
|
Cobos D, Nichols E, Kristen P, et al | PROSPERO
|
|
|
2/11/21
|
Rahayu YS, Anggriani A, Habibie H, et al | PROSPERO
|
|
|
2/11/21
|
Pannuti CM, dos Reis INR, Silveira MLS, et al | PROSPERO
|
|
|
2/11/21
|
Zhu N, Price J, Abbas M, et al | PROSPERO
|
|
|
2/11/21
|
van Hattum JC, Spies JL, Verwijs SM, et al | PROSPERO
|
|
|
2/11/21
|
Najt P, Richards HL, Fortune D | PROSPERO
|
|
|
2/11/21
|
Mayr V, Gartlehner G, Glechner A, et al | PROSPERO
|
|
|
2/11/21
|
Ghashghaee A, Kan FP, Raoofi S, et al | PROSPERO
|
|
|
2/11/21
|
Ghashghaee A, Rezaei S, Hosseinipalangi Z, et al | PROSPERO
|
|
|
2/11/21
|
Bright K, Devoe D, Dimitropoulos G, et al | PROSPERO
|
|
|
2/10/21
|
Harmon J, Guilhermino M, Ritruechai S, et al | PROSPERO
|
|
|
2/10/21
|
Sadana D, Ayala AP, Fowler R, et al | PROSPERO
|
|
|
2/10/21
|
Mathias EG, Anupama DS, Nayak BS, et al | PROSPERO
|
|
|
2/10/21
|
Jamal RF, Chakraborthy T | PROSPERO
|
|
|
2/10/21
|
Johnston B, Dönmez ÇF, Mayland C, et al | PROSPERO
|
|
|
2/10/21
|
Chow R, Im J, Chiu N, et al. | medRxiv
Aim: To conduct a systematic review and meta-analysis to report on adverse outcomes among COVID-19 patients by statin usage.
|
|
|
2/9/21
|
Marshall-Andon T, Berger-Gillam T, Walsh S, et al | PROSPERO
|
|
|
2/9/21
|
Mezarina Mendoza JPI, Salcedo Bolívar GT, Castañeda Palacios RDP, et al | PROSPERO
|
|
|
2/9/21
|
Alza-Arcila J, Cajamarca-Baron K, Guavita-Navarro D | PROSPERO
|
|
|
2/9/21
|
Omrani O, Sheppard H, Tleyjeh I, et al | PROSPERO
|
|
|
2/9/21
|
Figueiredo K, Corrêa K, Silva F | PROSPERO
|
|
|
2/9/21
|
Wei SQ, Bertrand MB, Liu S, et al | PROSPERO
|
|
|
2/9/21
|
Haghpanah S, Hosseini-Bensenjan M, Karimi M, et al | PROSPERO
|
|
|
2/9/21
|
Fujita-Rohwerder N, Zens Y, Beckmann L, et al | PROSPERO
|
|
|
2/9/21
|
Liu M, Wang Z, Lu T | PROSPERO
|
|
|
2/9/21
|
Chen MB, Wang H, Zheng QH, et al | PROSPERO
|
|
|
2/9/21
|
Kunutsor S, Seidu S, Khunti K | PROSPERO
|
|
|
2/9/21
|
Easom N, Mason P, Shah R, et al | PROSPERO
|
|
|
2/9/21
|
Tran TH, Pelland-Marcotte MC | PROSPERO
|
|
|
2/9/21
|
Xin W, Chen S, Dong S | PROSPERO
|
|
|
2/9/21
|
Domingo FR, Garcia AJ, Boland L, et al | PROSPERO
|
|
|
2/9/21
|
Kayi I, Madran B, Keske ?, et al | PROSPERO
|
|
|
2/9/21
|
de Pinho LG, Fonseca C, do Céu Marques M, et al | PROSPERO
|
|
|
2/8/21
|
Della Valle PG, Nucci D, Bonaccio M, et al | PROSPERO
|
|
|
2/8/21
|
Zeng N, Bao Y, Li C, et al | PROSPERO
|
|
|
2/8/21
|
Ferket B, Dijk S, Klein S, et al | PROSPERO
|
|
|
2/8/21
|
Chua EX, Abosamak MF, Mohd Zahir SMIS, et al | PROSPERO
|
|
|
2/8/21
|
Zhang S, Chen Z | PROSPERO
|
|
|
2/8/21
|
Li Y, Zhang J, Li S, et al. | Medicine
|
|
|
2/8/21
|
Jawaid A, Raison N | PROSPERO
|
|
|
2/8/21
|
El-Ramly T, Raut A, Ibrahim Y, et al | PROSPERO
|
|
|
2/8/21
|
Zhang M, Wang S, Hu T, et al. | medRxiv
Aim: To better understand the role of human mobility in the COVID-19 pandemic.
|
|
|
2/8/21
|
Robinson R, Prakash V | PROSPERO
|
|
|
2/8/21
|
Mitra S, Ling RR, Tan CS, et al | PROSPERO
|
|
|
2/8/21
|
Kannan S, Khanna P, Sarkar S | PROSPERO
|
|
|
2/8/21
|
Bikkannavar P, Ali Y, Angus-Leppan H | PROSPERO
|
|
|
2/8/21
|
Amarasekera AT, Li C, C. Raina M, et al | PROSPERO
|
|
|
2/8/21
|
Wang HR, Fu XY, Meng D, et al | PROSPERO
|
|
|
2/8/21
|
Systematic review of SARS-CoV-2 genetic variants characterization reported in the current literature
Chaparro Solano HM, Ruiz-Sternberg AM, Pinzon-Rondon AM, et al | PROSPERO
|
|
|
2/8/21
|
Zhu X, Luo Z, Chen Y, et al. | Medicine
|
|
|
2/8/21
|
Beukes E, Manchaiah V, Ulep A, et al | PROSPERO
|
|
|
2/8/21
|
Oton T, Carmona L | PROSPERO
|
|
|
2/5/21
|
Harwood R, Kenny S, Smith CT, et al | PROSPERO
|
|
|
2/5/21
|
Delanerolle G, Hapangama D, Shi JQ, et al | PROSPERO
|
|
|
2/5/21
|
Delanerolle G, Shetty A, Shi JQ, et al | PROSPERO
|
|
|
2/5/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/5/21
|
Wei GX, Hao W, Qiuxia S, et al | PROSPERO
|
|
|
2/5/21
|
Xu J, Liu H, Fan Y, et al. | SSRN
Aim: To investigate the efficacy of TCM medicine in the treatment for COVID-19 based on the data from randomized controlled trials (RCTs) clinical studies. UPDATED
|
|
|
2/5/21
|
Jimenez-Cebrian AM, Garcia-Podadera B, Castro-Mendez A | PROSPERO
|
|
|
2/5/21
|
Chiu L, Chow R, Chiu N, et al. | medRxiv
Aim: To report on the state of the current literature on the use of colchicine in COVID-19 and to investigate the reported clinical outcomes in COVID-19 patients by colchicine usage.
|
|
|
2/5/21
|
Yang J, Shah P | PROSPERO
|
|
|
2/5/21
|
Raygoza-Cortez K, Saenz-Flores M, Flores-Rodriguez A, et al | PROSPERO
|
|
|
2/5/21
|
Rotshild V, Matok I, Raccah BH | PROSPERO
|
|
|
2/5/21
|
Azizi S, Taghizadeh S, Montazeri F, et al | PROSPERO
|
|
|
2/5/21
|
Donkor A, Atuwo-Ampoh VD, Opie C, et al. | Research Square
Aim: To identify strategies adopted by radiotherapy centres in low and middle-income countries (LMICs) to mitigate the effects of COVID-19.
|
|
|
2/5/21
|
Mora PPM, Begle C, Chen C, et al | PROSPERO
|
|
|
2/5/21
|
Gattas S, O'Reilly F, Scerif G | PROSPERO
|
|
|
2/5/21
|
Gupta A, Ovenden C | PROSPERO
|
|
|
2/5/21
|
Wei GW, Hao W, Ning L, et al | PROSPERO
|
|
|
2/5/21
|
Pentecost H, Lewis A | PROSPERO
|
|
|
2/5/21
|
Trott M, Pardhan S, Vaughan M | PROSPERO
|
|
|
2/4/21
|
Schwendinger F, Infanger D, Schmidt-Trucksass A | PROSPERO
|
|
|
2/4/21
|
Comparison of efficacy and safety of different vaccines to prevent COVID-19: a network meta-analysis
Panunzi S, Maltese S, Mingrone G, et al | PROSPERO
|
|
|
2/4/21
|
Qing X, Xu W, Zhang Y | PROSPERO
|
|
|
2/4/21
|
Stevanato KP, da Silva VL, Silva GM, et al | PROSPERO
|
|
|
2/4/21
|
Kabbani D, Sonpar A, Benson W, et al | PROSPERO
|
|
|
2/4/21
|
Minchin J, Smith E | PROSPERO
|
|
|
2/4/21
|
Tegegne K, Wagnaw F, Eyayu D | PROSPERO
|
|
|
2/4/21
|
Hoshi K, Ikebe T, Ota Y, et al | PROSPERO
|
|
|
2/4/21
|
Sevillano SB, Fernandez MF, Vasquez-Vertiz D, et al | PROSPERO
|
|
|
2/4/21
|
Amer Y, Minhas M, Alkhamis W, et al | PROSPERO
|
|
|
2/4/21
|
Dong F, Lv Y, Ji X, et al | PROSPERO
|
|
|
2/4/21
|
Prabani KIP, HDWT Damayanthi Dassanayake | PROSPERO
|
|
|
2/4/21
|
Su Z, McDonnell D, Liang B, et al. | Syst Rev
|
|
|
2/4/21
|
Faical A, Ramos R, Souza E, et al | PROSPERO
|
|
|
2/4/21
|
Katsura C, Kankam H, Hourston G, et al | PROSPERO
|
|
|
2/4/21
|
Hanrahan C, Peetluck L, Golub J | PROSPERO
|
|
|
2/4/21
|
Wafa IA, Pramtama NR, Budi DS, et al | PROSPERO
|
|
|
2/4/21
|
Zhang QQ, Zhong BL, Li HM, et al | PROSPERO
|
|
|
2/4/21
|
Ghasemian R, Shamshirian A, Heydari K, et al. | medRxiv
Aim: To review the evidence on the role of vitamin D in COVID-19.
|
|
|
2/4/21
|
Nyberg A, Rajaleid K, Demmelmaier I | PROSPERO
|
|
|
2/3/21
|
Kiran S, Sevim F | PROSPERO
|
|
|
2/3/21
|
Vijayan M, Kilivanan ANH | PROSPERO
|
|
|
2/3/21
|
Ngan GYK, Ng KY, Wong KH, et al | PROSPERO
|
|
|
2/3/21
|
Tian X, Ying R, Zhang C, et al | PROSPERO
|
|
|
2/3/21
|
Szako L, Farkas N, Kiss S, et al. | Trials
|
|
|
2/3/21
|
Nafea A, Mahmoud A, Elanany I, et al | PROSPERO
|
|
|
2/3/21
|
Cilar L, Stiglic G | PROSPERO
|
|
|
2/3/21
|
Hill A, Heath K, Garratt A, et al | PROSPERO
|
|
|
2/3/21
|
Nayak A, Siddharth KK, Ashwini DL, et al | PROSPERO
|
|
|
2/3/21
|
Hoang MP Snidvongs K, Sommer D, et al | PROSPERO
|
|
|
2/3/21
|
Klassen SA, Senefeld J, Johnson PW, et al. | medRxiv
Aim: To determine the effect of COVID-19 convalescent plasma on mortality.
|
|
|
2/2/21
|
Rao N, Kim J | PROSPERO
|
|
|
2/2/21
|
Rees N, Williams J, Hogan C, et al | PROSPERO
|
|
|
2/2/21
|
Cruciani M, Marano G, Mengoli C, et al | PROSPERO
|
|
|
2/2/21
|
Valencia EJD, Cardenas AC, Pintor PMR, et al | PROSPERO
|
|
|
2/2/21
|
Abedin M, Wahab A, Rahman F | PROSPERO
|
|
|
2/2/21
|
Guo X, Wang H, Li N, et al | PROSPERO
|
|
|
2/2/21
|
Chen MB, Wang H, Zheng QH, et al | PROSPERO
|
|
|
2/2/21
|
Shao T, Zhao M, Zhou D, et al | PROSPERO
|
|
|
2/2/21
|
Fong HX, Golden K, Cornish K, et al | PROSPERO
|
|
|
2/2/21
|
Park J, Lee JH | PROSPERO
|
|
|
2/2/21
|
Giuliani M, Caponio VCA | PROSPERO
|
|
|
2/2/21
|
Prediction Models for Severe Manifestations and Mortality due to COVID-19: A Rapid Systematic Review
Miller J, Tada M, Goto M, et al. | medRxiv
Aim: To evaluate published reports of prediction models for severe illnesses caused COVID-19. UPDATED
|
|
|
2/2/21
|
Ruiz M, de Oliveira K, de Oliveira J, et al | PROSPERO
|
|
|
2/2/21
|
Cao Y, Zhai Y, Hiyoshi A | PROSPERO
|
|
|
2/2/21
|
Caulley L, Schramm D, Cooper C, et al | PROSPERO
|
|
|
2/2/21
|
Witarto AP, Witarto BS, Er Putra AJ, et al | PROSPERO
|
|
|
2/2/21
|
Alnagar A, Almaghraby A | PROSPERO
|
|
|
2/2/21
|
Akbar M, Pranata R, Wibowo A, et al | PROSPERO
|
|
|
2/2/21
|
Cai C, Peng Y, Zeng S | PROSPERO
|
|
|
2/2/21
|
Liang Q, Song Q, Liang N, et al | PROSPERO
|
|
|
2/1/21
|
Rycroft C, Underwood T | PROSPERO
|
|
|
2/1/21
|
Sales-Peres S, Azevedo-Silva L, Castilho AV, et al | PROSPERO
|
|
|
2/1/21
|
Kim MS, Seong D, Li H, et al. | SSRN
Aim: To evaluate the comparative efficacy of N95, surgical/medical, and non-medical facemasks in preventing respiratory virus infection.
|
|
|
2/1/21
|
Ciapponi A, Bardach A, Comande D, et al | PROSPERO
|
|
|
2/1/21
|
Keske S, Ergönül Ö | PROSPERO
|
|
|
2/1/21
|
Indarto F, Halim FS, Tjang YS | PROSPERO
|
|
|
2/1/21
|
Wang Z, Liu H, Wu M, et al. | Research Square
Aim: To systematically review the therapeutic reports on COVID-19 treated with integrated herbal medicine “Lianhua-Qingwen”and Western medicine to evaluate the efficacy and safety of the treatment.
|
|
|
2/1/21
|
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | medRxiv
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
|
|
|
2/1/21
|
Bach-Mortensen A, Verboom B, Esposti MD | medRxiv
Aim: To identify, appraise, and synthesise the available research on ownership variation in COVID-19 outcomes (outbreaks, infections, deaths, shortage of personal protective equipment (PPE) and staff) across for-profit, public, and non-profit care homes for older people. UPDATED
|
|
|
2/1/21
|
Vio R, Proietti R, Andrea G, et al | PROSPERO
|
|
|
2/1/21
|
Vasquez AV, Cuevas AG, Bastidas AAR, et al | PROSPERO
|
|
|
2/1/21
|
Kalaij AGI, Dirjayanto VJ | PROSPERO
|
|
|
2/1/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
2/1/21
|
Snow T, Saleem N, Burns H, et al | PROSPERO
|
|
|
2/1/21
|
Bakanaite E, Rowe S, Pitman A | PROSPERO
|
|
|
1/29/21
|
Thakur B & Pathak M | medRxiv
Aim: To assess the burden among three group of population, i.e., frontline healthcare workers (FHW), non-frontline healthcare workers (NFHW) and general who are not healthcare workers.
|
|
|
1/29/21
|
Jdiaa S, El Alayli A, Mansour R, et al | PROSPERO
|
|
|
1/29/21
|
e Souza Lopes AKKL, Apolinario TA, Kamiyama SY, et al | PROSPERO
|
|
|
1/29/21
|
Tang Z, Li M, Chen W, et al. | Medicine
|
|
|
1/29/21
|
Baral S, Rao A, Twahirwa Rwema JO, et al. | medRxiv
Aim: To characterize the impact of COVID-19 on HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.
|
|
|
1/29/21
|
Jingyi G, Ma Y, Wu Z, et al | PROSPERO
|
|
|
1/29/21
|
Lepere P, Escarguel B, Yolartiran S, et al. | medRxiv
Aim: To address the question: Can early home treatment with AZM alone or with zinc help prevent hospitalisation, death, and long-COVID-19?
|
|
|
1/29/21
|
Milovanovic L, Hessey E, Sebastianski M, et al. | BMJ Open
Aim: To identify epidemiological factors, treatments and complications that predict mortality among critically ill patients with COVID-19.
|
|
|
1/29/21
|
Lee ZX, Ang E, Lim XT | PROSPERO
|
|
|
1/29/21
|
Palo SK, Mishra BK, Dubey S, et al | PROSPERO
|
|
|
1/29/21
|
Smith V, Flaherty J, Matvienko-Sikar K, et al | PROSPERO
|
|
|
1/29/21
|
Benedetti F, Benros ME, Branchi I, et al | PROSPERO
|
|
|
1/29/21
|
Kang Z, Yang J | PROSPERO
|
|
|
1/29/21
|
Iglesias JG, Howlett N, Breslin G, Bartington S, et al | PROSPERO
|
|
|
1/29/21
|
Grieve S, Rabe A, Matthys A, et al | PROSPERO
|
|
|
1/29/21
|
Matu J, Feeley A, Mabbs L, et al | PROSPERO
|
|
|
1/29/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/29/21
|
St Denny E, Cairney P, Mitchell H | PROSPERO
|
|
|
1/29/21
|
Ibrahim M, Osman A, Karrar K, et al | PROSPERO
|
|
|
1/29/21
|
Marconcin P, Peralta M, Ihle A, et al | PROSPERO
|
|
|
1/28/21
|
Octavius GS, Tan R, Pratama TA, et al | PROSPERO
|
|
|
1/28/21
|
Fu S, Li Z, Yuan L, et al | PROSPERO
|
|
|
1/28/21
|
Abbas K, Shah J, El-Sahat N, et al. | Research Square
Aim: To review the evidence on the clinical features and management of transplant patients with COVID-19.
|
|
|
1/28/21
|
Roshdy A, El Sayed I, Moursi F | PROSPERO
|
|
|
1/28/21
|
Digamo K, Tolossa D | PROSPERO
|
|
|
1/28/21
|
Wang Q, Zhu H, Ge L, et al | PROSPERO
|
|
|
1/28/21
|
Liu F, Tan A | PROSPERO
|
|
|
1/28/21
|
Dobbins M | National Collaborating Centre for Methods and Tools
|
|
|
1/28/21
|
Castaneda-Sabogal A, Chambergo-Michilot D, Toro-Huamanchumo CJ, et al. | medRxiv
Aim: To assess the outcomes of ivermectin in ambulatory and hospitalized patients with COVID-19.
|
|
|
1/28/21
|
Liu X, Xiao J, Wang H, et al | PROSPERO
|
|
|
1/28/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/28/21
|
Wei GX, Wang H, Song Q, et al | PROSPERO
|
|
|
1/28/21
|
Han T, Ma S, Sun C, et al. | medRxiv
Aim: To review the evidence on the anti-inflammatory effects of hypoglycemic agents in patients with diabetes and COVID-19.
|
|
|
1/28/21
|
Sun N, He Y, Han X, et al | PROSPERO
|
|
|
1/28/21
|
Subramaniam A, Lim ZJ, Ashwin S, et al | PROSPERO
|
|
|
1/28/21
|
Epton T, Byrne-Davis L, Hart J, et al | PROSPERO
|
|
|
1/27/21
|
Pavlov I, He H, McNicholas B, et al. | Research Square
Aim: To synthesize the available evidence on the efficacy of APP.
|
|
|
1/27/21
|
Andrianto A, Al-Farabi MJ, Nugraha RA, et al. | medRxiv
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
|
|
|
1/27/21
|
Luthra R, Parveen R, Bajpai R, et al | PROSPERO
|
|
|
1/27/21
|
Cherrie J, Cherrie M, Davis A, et al. | medRxiv
Aim: To evaluate the evidence for air and surface contamination of workplace environments with SARS-CoV-2 RNA and the quality of the methods used to identify actions necessary to improve the quality of the data.
|
|
|
1/27/21
|
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | medRxiv
Aim: To evaluate the prevalence and case fatality rate of COVID-19 in patients with ESRD with RRT.
|
|
|
1/27/21
|
Nafea A, Altaweel A, Abdelrahman A, et al | PROSPERO
|
|
|
1/27/21
|
Gonçalves RL, Gonçalves DG, Coelho TR, et al | PROSPERO
|
|
|
1/27/21
|
A-Lai GH, Xu ZJ, Lin YD | PROSPERO
|
|
|
1/27/21
|
Almeida C, Souza T, Rossetto M | PROSPERO
|
|
|
1/27/21
|
Kunzler AM, Roethke N, Linder S, et al | PROSPERO
|
|
|
1/27/21
|
Andreas M, Piechotta V, Becker G, et al | PROSPERO
|
|
|
1/27/21
|
Imtiaz S, Nafeh F, Russell C, et al | PROSPERO
|
|
|
1/27/21
|
Pranata R, Akbar M, et al | PROSPERO
|
|
|
1/27/21
|
Kohli S, Menon GR, Ketharam A, et al | PROSPERO
|
|
|
1/26/21
|
Morais LSF, de Araujo GT, Lombardi LA, et al | PROSPERO
|
|
|
1/26/21
|
Almuqarrab F, Almohssen A | PROSPERO
|
|
|
1/26/21
|
Kwizera A, Rochwerg B, Kabatooro D | PROSPERO
|
|
|
1/26/21
|
Weir N, Kurdi A, Mueller T | PROSPERO
|
|
|
1/26/21
|
Kunzler AM, Roethke N, Lindner S, et al | PROSPERO
|
|
|
1/26/21
|
Lim C, Sim J | PROSPERO
|
|
|
1/26/21
|
Leon E, Lopez L, de la Pava C | PROSPERO
|
|
|
1/26/21
|
Tenawe H, Abuzuaiter I | PROSPERO
|
|
|
1/26/21
|
Fu S, Tian X, Zhang K | PROSPERO
|
|
|
1/26/21
|
Mitratza M, Goodale BM, Downward GS, et al | PROSPERO
|
|
|
1/26/21
|
Loh CH, Oh CC | PROSPERO
|
|
|
1/26/21
|
Deng J, Zhou F | PROSPERO
|
|
|
1/26/21
|
Tamuzi JL, Nyasulu P, Bayele B | PROSPERO
|
|
|
1/26/21
|
Deng J, Zhou F | PROSPERO
|
|
|
1/26/21
|
Cardoso da Silva HE, Martins GN, Leite AF, et al | PROSPERO
|
|
|
1/26/21
|
Amir M, Sudharsono A, Adam ATS, et al | PROSPERO
|
|
|
1/25/21
|
Yang Q, Zhou J | PROSPERO
|
|
|
1/25/21
|
Colakar M, Erbaydar NP | PROSPERO
|
|
|
1/25/21
|
Chhibber A, Kharat A, Kneale D, et al | PROSPERO
|
|
|
1/25/21
|
Zuniga RAA, Villoria RAMG, Elizondo MV, et al. | medRxiv
Aim: To determine the clinical effectiveness of convalescent plasma employed in the treatment of hospitalized patients with diagnosis of COVID-19.
|
|
|
1/25/21
|
Nersesjan V, Amiri M, Kondziella D | PROSPERO
|
|
|
1/25/21
|
Weibel S, Popp M, Meybohm P, et al | PROSPERO
|
|
|
1/25/21
|
Lv Y, Dong F, Fan X, et al | PROSPERO
|
|
|
1/25/21
|
Vieira da Silva AKC, Patiño Escartina JE, Souza RB, et al | PROSPERO
|
|
|
1/25/21
|
Cardelli C, Zucchi D, Figliomeni A, et al | PROSPERO
|
|
|
1/25/21
|
Goves J, Body R | PROSPERO
|
|
|
1/25/21
|
Yamamoto S, Saito M, Tamura A, et al. | SSRN
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
|
|
|
1/25/21
|
Deng D, Chui J, Liang A | PROSPERO
|
|
|
1/25/21
|
Organ C, Shankar R, Zabel A, et al | PROSPERO
|
|
|
1/25/21
|
Miao J, Liu Z | PROSPERO
|
|
|
1/23/21
|
San Juan NV, Camilleri M, Jeans JP, et al. | medRxiv
Aim: To provide a detailed understanding of the characteristics of redeployment to ICU and training provision during the first year of the COVID-19 pandemic.
|
|
|
1/23/21
|
Qiu X, Nergiz AI, Maraolo AE, et al. | medRxiv
Aim: To critically appraise available data about secondary attack rates from people with asymptomatic and pre-symptomatic SARS-CoV-2 infection.
|
|
|
1/23/21
|
Ngo BT, Marik P, Kory P, et al. | medRxiv
Aim: To assess the options at the present time for release of pharmacologic agents to treat and to prevent COVID-19 while pursuing widespread vaccination in 2021.
|
|
|
1/22/21
|
Li F, Li Y, Zhang J, et al. | Medicine
|
|
|
1/21/21
|
Daniali H, Flaten MA | PROSPERO
|
|
|
1/21/21
|
Hilario-Gomez MM, Pinedo-Castillo L, Zumaran-Nunez CJ, et al | PROSPERO
|
|
|
1/21/21
|
Nna E, Alao MA, Ogunbosi B, et al. | Research Square
|
|
|
1/21/21
|
Developing a casual framework for COVID-19 infection: a systematic review of epidemiological studies
Dill O, Slimings C, Bain-Donohue S | PROSPERO
|
|
|
1/21/21
|
Ahmed MA< Sun C, Kim NH | PROSPERO
|
|
|
1/21/21
|
Bakhtiari N, Shoushtari MH, Barfar M, et al | PROSPERO
|
|
|
1/21/21
|
Stroehlein JK, Wallqvist J, Iannizzi C, et al | PROSPERO
|
|
|
1/21/21
|
Huntley B, Chauhan S, Berghella V, et al | PROSPERO
|
|
|
1/21/21
|
Rajwar E, Radhakrishnan R, Pundir P, et al | PROSPERO
|
|
|
1/21/21
|
Muhammad Kamil NMN, Noor NM, Zakaria N, et al | PROSPERO
|
|
|
1/21/21
|
Patterson PD, Miller R, Martin-Gill C, et al | PROSPERO
|
|
|
1/21/21
|
Kula B, Clancy CJ, Nguyen MG, et al. | medRxiv
Aim: To review the evidence from autopsy studies performed in persons with fatal COVID-19 to determine the prevalence of autopsy-proven tissue-invasive IMD and analyze patient-level data to assess potential risk factors.
|
|
|
1/21/21
|
Weibel S, Popp M, Meybohm P, et al | PROSPERO
|
|
|
1/21/21
|
Popp M, Schmid B, Herrmann J, et al | PROSPERO
|
|
|
1/21/21
|
Huntley B, Chauhan S, Mulder I, et al | PROSPERO
|
|
|
1/21/21
|
Pamungkas KMN, Lesmana Dewi PIS, | PROSPERO
|
|
|
1/20/21
|
Luo Y, Jan DR, Zheng M, et al | PROSPERO
|
|
|
1/20/21
|
Liu X, Lu L, Li X, et al | PROSPERO
|
|
|
1/20/21
|
Brogi E, Marino F | PROSPERO
|
|
|
1/20/21
|
Xun Y, Ren M, Wang P, et al | PROSPERO
|
|
|
1/20/21
|
Moreira V, Masarenhas P, Machado V, et al. | medRxiv
Aim: To critically appraise and compare the clinical performance of RT-PCR tests using oral saliva, deep-throat saliva/ posterior oropharyngeal saliva (DTS/POS), sputum, urine, feces, and tears/conjunctival swab [CS]) against standard specimens (NPS, OPS, or a combination of both). UPDATED
|
|
|
1/20/21
|
Dhital R, Shah R, Shrestha C, et al | PROSPERO
|
|
|
1/20/21
|
Minkove S, Torabi-Parizi P, Eichacker P, et al | PROSPERO
|
|
|
1/20/21
|
Lange B, Ott J, Karki J | PROSPERO
|
|
|
1/20/21
|
Preston N, Briggs L, Rocks P, et al | PROSPERO
|
|
|
1/20/21
|
Shanmugam C, Behring M, Luthra V, et al. | medRxiv
Aim: To identify reasons for variability in COVID-19 diagnostic tests in the early phase of the pandemic that might have contributed to the spread of COVID-19.
|
|
|
1/20/21
|
Luo Y, Jan DR, Zhang M, et al | PROSPERO
|
|
|
1/20/21
|
Morales-Cane I, Lopez-Soto PJ, de los Reyes Fernandez-Vega M | PROSPERO
|
|
|
1/20/21
|
Ryan B, Kirk M, Boland F, et al | PROSPERO
|
|
|
1/20/21
|
Brehmer C, Todkil D, Edeghere O | PROSPERO
|
|
|
1/20/21
|
Martha J, Pranata R, Lim M | PROSPERO
|
|
|
1/20/21
|
Silveira V, Viola P, Carvalho C, Nunes A | PROSPERO
|
|
|
1/19/21
|
Timpka T, Joud A, Spreco A, et al | PROSPERO
|
|
|
1/19/21
|
Elgendy IY, Elbadawi A | PROSPERO
|
|
|
1/19/21
|
Bhattacharyya A, Seth A, Srivastava N, et al. | Research Square
Aim: To summarize COVID-19’s impact based on symptoms, demographics, comorbidities, and demonstrates the association of demographics in cases and mortality in the United States.
|
|
|
1/19/21
|
Lee SG, Fralick M, Tang G, et al. | medRxiv
Aim: To describe the relationship between hemostatic laboratory parameters and important clinical outcomes among adults with COVID-19.
|
|
|
1/19/21
|
Chen K, Yunusa I, Liu S, et al. | Preprints
Aim: To provide up-to-date qualitative and quantitative evidence of the epidemiology, clinical characteristics, laboratory data, and test the hypothesis that the distribution of symptoms, comorbidities, and severity would be different among patients different age groups, countries, and stages of outbreak. UPDATED
|
|
|
1/19/21
|
Yao H, Peng J, Zheng X, et al. | Research Square
Aim: To comprehensively review the available evidence identify the effectiveness and safety of remdesivir in patients with COVID-19.
|
|
|
1/19/21
|
Lipworth S, Rigby I, Cheng V, et al. | medRxiv
Aim: To assess the responsiveness and quality of clinical management guidelines (CMGs) in SARS, MERS and COVID-19 and determine whether this has improved over time.
|
|
|
1/19/21
|
Mbwogge M | medRxiv
Aim: To evaluate the effectiveness of mass testing and contact tracing in the suppression of COVID-19 compared to conventional Test and Trace in the UK.
|
|
|
1/19/21
|
Budhathoki P, Shhrestha D, Raut S, et al | PROSPERO
|
|
|
1/19/21
|
Azami-Aghdash S, Naghibi D, Khairy Y | PROSPERO
|
|
|
1/19/21
|
Tonapa SI, Saragih ID, Lee BO | PROSPERO
|
|
|
1/19/21
|
Mohsenpour A, Bozorgmehr K, Rohleder S, et al. | medRxiv
Aim: To synthesise the evidence on SARS-Cov-2 infection, transmission, outcomes of disease, effects of non-pharmaceutical interventions (NPI), and the effectiveness of targeted strategies for infection prevention and control (IPC).
|
|
|
1/19/21
|
Noureldin A, Othman M, Kazi S | PROSPERO
|
|
|
1/19/21
|
Panchal U, de Pablo GS, Moreno C, et al | PROSPERO
|
|
|
1/19/21
|
Sarkar S, Kannan S, Khanna P, et al | PROSPERO
|
|
|
1/19/21
|
Shi S, Huang D, Wang F, et al | PROSPERO
|
|
|
1/19/21
|
Tocilizumab therapy on COVID-19 patients mortality rate: a systematic review and meta-analysis study
Corbi G, Conti V | PROSPERO
|
|
|
1/18/21
|
A systematic review on mental health problems among nurses taking care of COVID 19 positive patients
Saini SK, Kalyan G, Dandapani M, et al | PROSPERO
|
|
|
1/18/21
|
Gonçalves RL, Silva de França NE, da Silva LN, et al | PROSPERO
|
|
|
1/18/21
|
Wu K, Zhang M, Zhou X | PROSPERO
|
|
|
1/18/21
|
Emara M, Alboraie M, Mahros A, et al | PROSPERO
|
|
|
1/18/21
|
Belletti A, Landoni G, Zangrillo A | PROSPERO
|
|
|
1/18/21
|
Longo M, Anomneze-Collins A, Mann M, et al | PROSPERO
|
|
|
1/18/21
|
Belletti A, Valsecchi G, Todaro G, et al | PROSPERO
|
|
|
1/18/21
|
Zhou C, Lou B, Duan F | PROSPERO
|
|
|
1/18/21
|
Tumminaro A, Favilla V | PROSPERO
|
|
|
1/18/21
|
Gonçalves RL, Lima GF, da Silva LN, et al | PROSPERO
|
|
|
1/16/21
|
LoCurto J, Lange BCL, Chang R, et al | PROSPERO
|
|
|
1/15/21
|
Papadopoulos VP, Koutroulos M, Zikoudi D, et al. | medRxiv
Aim: To provide further evidence regarding the key features of COVID-19-related acute metabolic emergencies in diabetes (DKA, EDKA, HHS, and DKA/HHS) by identifying all relevant case reports that can provide detailed patient data and summarizing their results together.
|
|
|
1/15/21
|
Obrero-Gaitan E, Lomas-Vega R, Cortes-Perez I | PROSPERO
|
|
|
1/15/21
|
Dogheim G, Abdel-Aziz E, Aboukhatwa M, et al | PROSPERO
|
|
|
1/15/21
|
Bello U, Mahmud FA, Jalo HA, et al | PROSPERO
|
|
|
1/15/21
|
Avci YD, Gozum S | PROSPERO
|
|
|
1/15/21
|
Fanti E, Milesi A | PROSPERO
|
|
|
1/15/21
|
Guo Q, Song Y, Ma L, et al | PROSPERO
|
|
|
1/15/21
|
Reis L, Santos E, Pimenta G, et al | PROSPERO
|
|
|
1/15/21
|
Li F, Liang W, Shang B, et al | PROSPERO
|
|
|
1/15/21
|
Liu L, Ni SY | PROSPERO
|
|
|
1/15/21
|
Williams J, Goulding L, Jordan H, et al | PROSPERO
|
|
|
1/15/21
|
Franco CHC, Ospina N, Bermudez IS | PROSPERO
|
|
|
1/15/21
|
Lee M, Shin J | PROSPERO
|
|
|
1/15/21
|
Ji Y, Qiu G, Song D, et al. | Medicine
|
|
|
1/15/21
|
Snow T, Saleem N, Singer M, et al | PROSPERO
|
|
|
1/15/21
|
Li S, Zhang J, Li F, et al. | Medicine
|
|
|
1/15/21
|
Said J, Perez-Chada L, Elman S, et al | PROSPERO
|
|
|
1/14/21
|
Vale C, Sterne J, Tierney J, et al | PROSPERO
|
|
|
1/14/21
|
| CADTH
|
|
|
1/14/21
|
Wendt GW, Ferreto L, Ximenez J, et al | PROSPERO
|
|
|
1/14/21
|
Beaudart C, Diep AN, Locquet M, et al | PROSPERO
|
|
|
1/14/21
|
Gonçalves AK, Medeiros K, Sarmento A, et al | PROSPERO
|
|
|
1/14/21
|
Li Y, Yang JZ, Li ZY | PROSPERO
|
|
|
1/13/21
|
Ghahramani S, Azmand S, Shahabi S | PROSPERO
|
|
|
1/13/21
|
Hashan MR, Smoll N, King C, et al | PROSPERO
|
|
|
1/13/21
|
Eshetie S, Vinery K, Gray D | PROSPERO
|
|
|
1/13/21
|
Yonenaga K, Itai S, Hoshi K | PROSPERO
|
|
|
1/12/21
|
Octavius GS, Chandra S, Wijaya JH, et al. | PROSPERO
|
|
|
1/12/21
|
Yetmar Z, Tleyjeh I, Chesdachai S | PROSPERO
|
|
|
1/12/21
|
Udoh A, Akpan M, Olojo I, et al. | PROSPERO
|
|
|
1/12/21
|
Li C, Islam N, Gutierrez JP, et al. | PROSPERO
|
|
|
1/12/21
|
Herrera AM, Cortes K, Estrada-Orozco K | PROSPERO
|
|
|
1/12/21
|
Samaranayake L, Fakhruddin K, Ngo H, et al. | PROSPERO
|
|
|
1/12/21
|
Nowroozi A, Karimi A, Alilou S, et al. | PROSPERO
|
|
|
1/12/21
|
Tu J, Xie T, Zhang X, et al. | PROSPERO
|
|
|
1/12/21
|
Benites-Meza JK, Mamani-Garcia CS, Bustamante-Paytan D, et al. | PROSPERO
|
|
|
1/12/21
|
Sarma P, Bhattacharyya A, Kaur H, et al. | PROSPERO
|
|
|
1/12/21
|
Turki A, Abbas KS, Makram AM, et al. | PROSPERO
|
|
|
1/12/21
|
Rivera-Ramierz P, Fiestas-Saldarriaga F, Nys BL | PROSPERO
|
|
|
1/12/21
|
Chan YY, Rahman ZA, Harun A, et al. | PROSPERO
|
|
|
1/12/21
|
Romiti GF, Proietti M | PROSPERO
|
|
|
1/12/21
|
Romiti GF, Corica B | PROSPERO
|
|
|
1/12/21
|
Hariyanto TI, Rosalind J, Halim DA, et al. | PROSPERO
|
|
|
1/12/21
|
Reyad O, Ghazy R, El-Deen AN, Alaa N, et al. | PROSPERO
|
|
|
1/12/21
|
Li P, Xu A, Li M, et al. | PROSPERO
|
|
|
1/12/21
|
Kumar A, Kumar D V, Sharma A, et al. | PROSPERO
|
|
|
1/12/21
|
Ridjab DA, Ivan I, Budiman F, et al. | PROSPERO
|
|
|
1/12/21
|
Udoh A, Akpan M, Kpokiri E, et al. | PROSPERO
|
|
|
1/12/21
|
Imani-Nasab MH, Hashemi S, Bajoulvand R, et al. | PROSPERO
|
|
|
1/12/21
|
Khan S, Haleem MH | PROSPERO
|
|
|
1/12/21
|
Ogungbe B, Asala A, Kumbe B, et al. | PROSPERO
|
|
|
1/12/21
|
Lee B, Chen X, Yu G, et al. | PROSPERO
|
|
|
1/12/21
|
Pereira AM, da Silveira Moreira R, Adagilson, et al. | PROSPERO
|
|
|
1/12/21
|
Fiocca V, Suen V | PROSPERO
|
|
|
1/12/21
|
Czakert JP, Ballesteiros GP, Berger R | PROSPERO
|
|
|
1/12/21
|
Iuo C, Huang L, Zhao F, et al. | PROSPERO
|
|
|
1/12/21
|
Yi T, Peng W, Tu | PROSPERO
|
|
|
1/12/21
|
Khodakarami N, Olatunki E, Kassabian M | PROSPERO
|
|
|
1/11/21
|
Singh A, Yadav M, Sankar J | PROSPERO
|
|
|
1/11/21
|
Kariyawasam R, Dingle T, Chen J, et al. | PROSPERO
|
|
|
1/11/21
|
Berg K, Hsu C, Considine J, Pawar R, et al. | PROSPERO
|
|
|
1/11/21
|
Zhan T, Chen H, Li Y | PROSPERO
|
|
|
1/11/21
|
Gonçalves RL, Pereira Lopes TC, Cordeiro SA, et al. | PROSPERO
|
|
|
1/11/21
|
Aggarwal AM, Agarwal R, Dhooria S, et al. | PROSPERO
|
|
|
1/11/21
|
Aggarwal AN, Agarwal R, Dhooria S, et al. | PROSPERO
|
|
|
1/11/21
|
Kojima A, Nisijima C, Sato Y, et al. | PROSPERO
|
|
|
1/11/21
|
Gonçalves AK, Medeiros K, Sarmento A, et al. | PROSPERO
|
|
|
1/11/21
|
Kirkham A, Allan D, Shorr R, et al. | PROSPERO
|
|
|
1/11/21
|
Dowsett L, Clement F, Tricco A, et al. | PROSPERO
|
|
|
1/11/21
|
Johns G, Waddington L, Samuel V | PROSPERO
|
|
|
1/11/21
|
Santos J, Fernandes A, Maia L, et al. | PROSPERO
|
|
|
1/11/21
|
Farias GS, Nascimento Salazar TC, Barros GR | PROSPERO
|
|
|
1/11/21
|
Wang Y, Tian X, Liu B, et al. | PROSPERO
|
|
|
1/11/21
|
Jiang L, Li Y, Feng X | PROSPERO
|
|
|
1/10/21
|
da Silva Kist MLO, Drumond Costa CA, Ramos Garcia PC, et al. | PROSPERO
|
|
|
1/9/21
|
Sriharan A, Ratnapalan S, Tricco AC, et al. | medRxiv
Aim: To identify the causes of occupational stress and burnout in women in medicine, nursing, and other health professions during the COVID-19 pandemic and interventions that can support female health professionals deal with this crisis through a rapid review.
|
|
|
1/8/21
|
Delanerolle G, Shi J, Ramakrishnan R, Phiri P | PROSPERO
|
|
|
1/8/21
|
Kant R, Yadav P, Khapre M | PROSPERO
|
|